header
string | sequence
string | class
string | mechanism
string | type
string | label
int64 |
---|---|---|---|---|---|
MEG_8737|Drugs|betalactams|Class_B_betalactamases|VIM | ATGTTCAAACTTTTGAGTAAGTTATTGGTCTATTTGACCGCGTCTATCATGGCTATTGCGAGTCCGCTCGCTTTTTCCGTAGATTCTAGCGGTGAGTATCCGACAGTCAGCGAAATTCCGGTCGGGGAGGTCCGGCTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCAGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAGAAGCAAATTGGACTTCCTGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGTAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAACTCTTCTATCCTGGTGCTGCGCATTCGACCGACAACTTAGTTGTGTACGTCCCGTCTGCGAGTGTGCTCTATGGTGGTTGTGCGATTTATGAGTTGTCACGCACGTCTGCGGGGACCGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCATTGAGCGGATTCAACAACACTACCCGGAAGCACAGTTCGTCATTCCGGGGCACGGCCTGCCGGGCGGTCTAGACTTGCTCAAGCACACAACGAATGTTGTAAAAGCGCACACAAATCGCTCAGTCGTTGAGTAG | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8742|Drugs|betalactams|Class_B_betalactamases|YEM | ATGTTAAAAACAATATTACAATTTTTTGTTTTATTCACTGTAACTCAAGGTGCTTATGCATCTAAAATAGCATTGGTAAAATTAAGTGATAATCTTTATGTTGTCGAGGACGACTATTATTACAGAGAAAACTCCATGGTTTACATTGGTAAAGACTATATTACCGTTATTGGTGCCACCTGGACACCGGATACAGCTAAAGAATTAGATGCGCAAATCAAAAAAATAAGTAAAAAACCCATCGCTGAAGTTATCAATACCAATTATCATACGGACAGGGCCGGTGGTAATTTATATTGGAAAAGTATTGGTGCTGAATTGATTTCTACCAAAATGACGTATAATTTAATGGAAAAACATTGGCAAGATATTCTTGAGACTACCCGTAAAGGGTACGATGGCTTCCCTGATATTCCCCTTGTTTTGCCGACAAAGACTTTTGATAATAACTTTGAACTACAAAATGGCGAGATAAAAGCTATCTACACAGGTGAATCTCATACTCCTGACGGAATATTTGTTTATTTTCCGAAGGAAAAAACCTTATATGGAAATTGCATAATTAAAGAGAAATTAGGTAATTTGGCCTCTGCTAATATAAAGGAGTACCCTAAGACCTTACAGAAACTTAAAAATTTAAATCTCGATATAAAGACAGTTGTCGGTGGTCATGACTCACCAATACATGGTTCCGAACTTATCGATAGCTATAAAAAACTAATCGAAGCCGCTAATAAGTAA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8273|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|NORC | ATGAATGAAACGTATCGCGGGGGCAACAAGTTAATCTTAGGTATTGTATTAGGTGTTATTACATTTTGGTTGTTTGCACAATCACTTGTAAATGTTGTGCCAAATTTACAACAAAGTTTTGGTGCAGACATGGGAACAATTAGTATTGCGGTAAGTCTAACCGCACTATTTTCAGGCATGTTTGTTGTTGGAGCAGGCGGCCTAGCAGATAAAATTGGACGCGTGAAAATGACAAATATCGGCTTATTATTAAGTATTATTGGTTCAGCATTAATTATTATTACAAATTTACCAGCATTGCTAATTTTAGGCCGTATTATACAAGGCGTATCAGCAGCGTGTATTATGCCTTCCACATTGGCCATTATGAAAACTTATTATGAGGGTGCTGAACGTCAGCGTGCCTTAAGCTATTGGTCTATCGGTTCTTGGGGTGGAAGTGGTATCTGTTCACTCTTCGGTGGGGCAGTTGCGACAACTATGGGTTGGAGATGGATTTTCATCTTCTCAATCATCGTTGCCGTACTTTCAATGTTACTCATCAAAGGGACGCCTGAAACGAAATCAGAAGTTACCAATACACATAAATTTGACGTTGCAGGTCTAATTGTTCTAGTAGTTATGTTATTAAGTTTAAACGTTGTCATTACTAAAGGTGCAGCACTTGGTTATACATCATTATGGTTCTTTGGTTTGATTGCAATCGTAATTGTAGCATTCTTTATTTTCTTAAATGTTGAGAAAAAAGTAGATAATCCGCTTATTGATTTTAAATTATTTGAAAATAAACCATATACAGGTGCAACGATTTCGAACTTCTTATTAAACGGTGTTGCAGGTACATTAATTGTAGCGAATACATTCGTACAACAAGGTTTAGGTTATACAGCATTGCAGGCAGGATACTTATCAATCACTTATTTAATCATGGTGTTATTGATGATTAGAGTTGGTGAAAAATTATTACAAAAAATGGGTTCTAAGCGACCAATGTTATTAGGTACATTCATTGTGATCATTGGTATTGCACTTATTTCATTAGTATTCTTACCAGGCATATTTTATGTTATCAGTTGTGTCGTAGGATATTTATGTTTTGGACTAGGCTTAGGTATTTATGCAACACCTTCTACAGATACAGCTATTTCAAATGCACCGTTAGATAAAGTTGGCGTTGCTTCAGGTATTTATAAAATGGCTTCATCACTTGGTGGTGCATTCGGTGTCGCAATTAGTGGTGCAGTATATGCCGGTGCAGTTGCTGCAACGAGCATTCATACAGGTGCGATGATTGCACTTTGGGTTAACGTATTAATGGGAATCATGGCATTTATCGCAATTTTATTTGCGATTCCTAATGATGATAAACGTGTCAAAGATGCGAAATAA | Drug and biocide resistance | Drug and biocide MFS efflux pumps | Multi-compound | 1 |
MEG_8241|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|MDE | ATGACGAAACATTTACAAGATTTTTTAATAACAGTTATCGCAGGTATGGGAATGTTATTATCCACCCTTGATACAGGTATTATCAATGTTGCATTATCCTTTTTGAGGGGACAATTTCAAACCACAACTAACATTGCCTCTTTTACAATAACTGGATATACTTTAGCATTAGCTATCTCTATCTTACCTTTAGGAGTATTAAGCGATAAATTTGGAAAGTTAAAGATTTCCTACTTAGGATTTGTACTTTTTGGACTGAGCTCCTTATTTTGTGGATTTGCTAATAGTATTGGCTGGCTCATTACTGGCCGGATTATTCAAGGAATGGGAGCGGCGGCTTTGCAAGCTACTTCAGCAGCTCTGATTACCACTTTAGTTTCCGAAGACCGCAAAAACAGTGCTATTAGTATTTTAGGAGTTATGATTGGCTTAGGACCTGTCCTCGGTCCTTCCTTAGGAGGCATACTACTTTCTTTAAATCTCTGGCGCTTTATTTTCTGGATTAATGTTCCCTTTGCTCTTATTGTCATCATTTGTAATCACTATCTCCTTACTAAAGTCTCCGAACAAACTAGTGAGTGGACATTAGATTCTCTTGGAACAGTTCTCAATGCTTCTATGTTGGTTTGTCTTCTCTTAGGACTATCCTTACTCAGTAAGCCTCACCTATTAGGTATCAGTCTTATTTTGATCATCATTAGTTTCTTGATCGGGATTTGGTTTTACCGTCTTGAATGCAGCAAAGAGAGTGCTCTTGTCAATGTCAAGGGGCTGAGCGAGAATCCTCGAGTACTTTCTTATCTTTTTCAAACGGTCGCTTTTGGTTTTGCCTCTGCAATGATATTCTTACTTCCACCCTTCATTTTTGAACAATTATATCATTTAGGAGTGGGGCAGACAGGCTTTCTTGTACTAGGAGCACCTGCAGGCCTGGTTCTTTTTTCAAGAATATCTGGTAAAATCAATGATGGCAGTAAAAATAAATCATTTAGCCATATTGGTTTGGGTATCATTATTTTATCCTTAATTTTCCTCCTACTTCTCACGCCTAGCTGGCCCTATTTATTCTTAACTTTAGGATTATTTATTTATGGTATTGGCGGAGGATACTTTCAGCCTGCTAATATGGCTAGTATTATGCTAGCTAGTCCTATGAAAATGCAAGGTAGCACAGGAGCATTGCAACGAATGGTACAAAACATTGCTATTTCAGCTGGTTCAGCCATTGGATCAACTTGCTTAAACCTTTGGTCAAATAATCTATTATTGGCTACCCGAATTGGCTGGGGAATTACACTCGTTCTAGTTATTCTCAGTTTAAAAGAACTAACACCATTTAAAATGACTAATAAAACAGAATAA | Drug and biocide resistance | Drug and biocide MFS efflux pumps | Multi-compound | 1 |
MEG_8693|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|SEPA | ATGATTGTGAACTTTTTCAAGCATAAATTTTATAATTTATTAACTACAATGATTGTTCTCTTTGTGTTTGTGTTGTCCGGTGCAATTTTTTTAACATTTCTAGGTTTTGGACTTTATGGTCTTAGCAGGATACTTATATACTTTAGGTTAGGTGATTTCACGTATAATAGAAATATGTATGATAATTTATTGTATTACGGTAGTTATATCATATTTGGTTATTTTATCATTTTTGCAGTCGAACATTTAATGGATTATTTTAGAAAGATGCTTCCTGAAAATGCATATTTTAGAGGAGCAACATTCCATTTAATATCTTATACGGTTGCTACTACATTATTTTATTTCATTATTCATTTACATTATGTGTATATTAATATTGATTTTTGGGTCATCATGGTAATCATAGGCTTTCTTTATGTATGTAAACTTCAATTTTACCCTGAAAGTAAAAATCTCAATAATAGAAAATAA | Drug and biocide resistance | Drug and biocide RND efflux pumps | Multi-compound | 1 |
MEG_8692|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|SDRM | ATGCGATTAAAGTCAATCATAACTGTTATAGCTTTAATATTAATTATGTTTATGTCAGCGATTGAATCATCTATTATTTCGCTTGCATTACCTACAATTAAACAAGATTTAAATGCAGGAAATTTAATTTCATTAATTTTTACAGCGTATTTTATCGCATTAGTAATTGCCAATCCTATAGTGGGAGAATTACTTTCGAGATTTAAAATTATTTATGTGGCAATTGCAGGATTACTTTTATTTAGTATAGGTAGTTTTATGTGTGGTTTAAGTACTAATTTTACTATGCTAATTATATCACGCGTGATACAAGGTTTTGGATCAGGTGTATTGATGTCATTATCGCAAATTGTTCCAAAGTTAGCATTTGAAATTCCGTTACGATATAAAATTATGGGCATAGTTGGCAGTGTTTGGGGTATTTCGAGTATCATTGGACCGCTTCTAGGTGGTGGTATATTAGAATTTGCAACATGGCATTGGTTATTCTACATAAATATACCGATTGCGATCATTGCCATTATATTAGTTATATGGACATTTCATTTTCCAGAGGAAGAAACAGTTGCTAAATCAAAATTTGATACTAAAGGGCTCACGCTATTTTATGTATTTATTGGATTGATTATGTTTGCTTTATTAAACCAACAGCTATTACTTTTAAATTTCTTGAGTTTTATCTTAGCTATCGTTGTGGCAATGTGTTTATTTAAAGTAGAAAAACATGTTTCTTCACCATTTTTACCTGTGGTTGAATTTAATCGTTCGATTACTTTAGTTTTTATAACGGACCTTCTAACAGCTATTTGTTTAATGGGATTCAATTTATATATTCCAGTCTACCTTCAAGAACAACTAGGATTATCTCCATTGCAAAGTGGATTGGTTATTTTTCCTTTATCTGTAGCTTGGATTACATTGAATTTTAATTTACATCGAATTGAAGCAAAACTATCAAGGAAAGTTATTTACTTACTATCATTTACATTGTTACTAGTAAGTAGTATTATCATTTCATTTGGTATTAAATTGCCGGTACTTATAGCATTTGTGTTAATTTTGGCAGGATTAAGTTTTGGATATATTTATACGAAAGATAGTGTAATTGTCCAAGAGGAAACTAGCCCATTACAAATGAAGAAAATGATGTCATTTTATGGATTAACTAAAAATCTTGGGGCATCAATAGGTTCAACAATAATGGGATATCTTTATGCGATACAATCAGGAATCTTTGGTCCAAACTTACACAATGTGTTAAGTGCTGTTGCTGTAATTAGCATTGGGCTTATTGTTTTATGGGTCGTATTTTTTAAAGAACAGTCATCTCAATCAAAAGAATAG | Drug and biocide resistance | Drug and biocide MFS efflux pumps | Multi-compound | 1 |
MEG_8628|Drugs|betalactams|Class_B_betalactamases|PFM | ATGAAGCTTATTAATATTCTGTCAGTCATCAGCCTGGCCTGCATTACCTCCCAGGTCTTCGCTAACAAGAGTGACTTGACCCTTACCCACTTCAAAGGCCCGCTCTACATCGTTGAAGACAAGGAATATGTGCAGGAGAACTCAATGGTCTACGTTGGCGAGCAACACATCACGGTTATTGGCGCAACCTGGACCCCAGCCACCGCTGAAAAGCTTGAGCAGGAAATCAGGAAAATCAGCCCCCTGCCCATCAAGGAGGTGATCAATACCAACTACCACACCGACCGCGCGGGAGGTAACGCCTACTGGAAGAAGCTCGGCGCCAGTATTGTCTCAACGCAGATGACCTATGACCTGGAAAAAAGCCAGTGGCGCAGTATTGTCGACTTTACCCGGCAAGGGATGGAGCACTATCCAATCCTGGAACAAAGCCTGCCAGACCAGGTATACCCGGGCAACTTCGACTTGCAAAACGGCCATGTTAGAGCACTGTATTTAGGCGCGTCTCACACCGAAGATGGGATTTTTGTGTACTTTCCAGAAGAGCGTGTGTTGTATGGAAACTGCATTCTCAAGGAAAAGCTGGGTAACATGACATTCGCGAATCGCAGCGAGTACCCGAAAACCCTGAAGAAATTGCAAGGGCTGATCCGCAGTGGTGAATTGCCCGTTGAAGCGATTATCGCAGGGCATAACTCACCGATACAGAACGTTGAGTTGATTGACCATTATCTGACCCTGCTTGAACACGGCGAGCAGTAA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8267|Drugs|betalactams|Class_B_betalactamases|NDM | ATGGAATTGCCCAATATTATGCACCCGGTCGCGAAGCTGAGCACCGCATTAGCCGCTGCATTGATGCTGAGCGGGTGCATGCCCGGTGAAATCCGCCCGACGATTGGCCAGCAAATGGAAACTGGCGACCAACGGTTTGGCGATCTGGTTTTCCGCCAGCTCGCACCGAATGTCTGGCAGCACACTTCCTATCTCGACATGCCGGGTTTCGGGACAGTCGCTTCCAACGGTTTGATCGTCAGGGATGGCGGCCGCGTGCTGTTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAGCAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATGGGCGGTATGGACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAACCAGCTTGCCCCGCAAGAGGGGCTGGTTGCGGCGCAACACAGCCTGACTTTCGCCGCCAATGGCTGGGTCGAACCAGCAACCGCGCCCAACTTTGGCCCGCTCAAGGTATTTTACCCCGGCCCCGGCCACACCAGTGACAATATCACCGTTGGGATCGACGGCACCGACATCGCTTTTGGTGGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACTGAGCACTACGCCGCGTCAGCGCGCGCGTTTGGTGCGGCGTTCCCCAAGGCCAGCATGATCGTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACTCATACGGCCCGCATGGCCGACAAGCTGCGCTGA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8291|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACCTTGCTTGGTTGTCAAAATTTTCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATGCTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACACTTCAAGCATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAACTTCACCAAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATGCCGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCAATTGAAGAGGTTAAATTTGCTTATGCTTTGGCAAATAAGCAGCTTGAATTTGACCAATCTGTGCAAAAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGGATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTTCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8688|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALB | ATGCTATTTTTATTTGAAGAAAAACCATTAGAAATTGAGAATAAACAGCTTATAAAACGTTTGTCATTTCATATCGAAGACCATGAGCATTTAGCCCTTATCGGTGTTAATGGTATTGGTAAATCTACGCTATTACATCATATTCATAAAAATGAATTGATTGATACAGCTATGATGGAACAAGATTTAAGTAAACATGATGATATTGATGTTATGGATTATGTCATGTCTGCATATCCAAAGTTAGTTGAATTGAGAAAAGATTTATCTGACATTGATTCTTTAAATAGTTATATAGAATTAGACGGATATAACGTTGAAAATAACATTATTATTGAAGGAAATAAATTAGGATTATCATCAACACATTTTGAGCAAAAGATAGGCACTTTAAGTGGTGGTGAGCAAACTAAAGTCTCATTTTTAAAAGTTATTTTATCAGATGCACCATTATTATTAATAGACGAACCAACTAACCATATGGATAAAGAGATGAAAGTGTGGTTAATAAAAGCTTTTAAATCAGAACAAAGAGCTATTCTATTCGTATCGCATGATAGAGAGTTTTTAAATGAAACACCAGATGCTATTTTAGAACTCACAAAAGATGGTGCAACTCGATATTCAGGTCATTATGATGATTATAAAAATCAAAAAGATATTGAAATTGAAACAGAAAAATTAAAATATGAAAAAGAACAGAAAGAACAAAAAGCAATAGAAGAAAGTATTAAGAAATACAAAGAATGGTATCAAAGGGCTGCTCAGAAAGCTTCTGTTCGTAGTCCATATGCTCAAAAACAATTAAGTAAATTAGCTAAAAGATTTAAATCAAAAGAACATCAGTTAAATCGTAAATTAGAAGAATCAAAATCTGATAATCCGTTAGAAGAAAATAAATCCTTTTCTATAGAAAATAATGAATTTAAATCACATTATTTAGTAAGATTCGAAAATGTTTCATTTTCATATAAGAGTCGTGAAATTTTTAAAGACACTTATTTTGAAATAAAGAGAAATCAAACTGTAATTATAGAAGGTAAAAATGGGTCCGGTAAATCTACATTGATACAATTAATTTTAGGTAACTTATTACCAATGAGTGGAGCTGTCAAAAAGCACCCAGACTTAGACATAGGATACTTCTCGCAAGATTTTCAAAATTTAAACCCAAACAACTCGGTATTAGAAGAAGTTATGGATATTGAGAATATGATGATAACAGACGCGAGGACTATTTTAGCGAGTTTTTATTTTGATAAGAGCAGGATGAATGATAAAGTTCGTCAGTTATCAATGGGAGAAAAGTGCAGGTTACAATTTGTAAAATTATATTTTTCTAACCCACACATCTTAATTTTAGATGAACCAACTAATTATTTTGATATTAGTATGCAAGAGAAAATCATACAATTAATCCAAAGTTTTAATGGTGCAGTAATTATTGTGTCGCATGATGAAATTTTTAAAGATGAAATAAGAGACCAAGTTTGGAAGATTGAAAACTGTAAGCTCATTCATGAAAATGTATCTATTAATACACCTATTGATGCTGAATCGATGAAGGATGAGTTAAAAATATTAGAGCAATATACAGATGAAAGAAATAAAGAAACAGACTTCTAG | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8689|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALC | ATGCTATTTTTATTTGAAAAAAAGTCTTTAGAGATTGACAATAAACTGCTCATACCTTCACTAACATTTATTATTGAAGAAAATGAACATTTGGCAATAGTCGGCATAAATGGTATCGGAAAATCTACACTTTTAAATAAAATCCATCATAAAGAAAATATTGAAACAGCAATGATGGAACAAGATTTAACTAAATATGGAACTTTAAATGTCATGGAGTATATTATGTTAACTTATCCACAATTATCATCGTTAAGAGAAAATCTAAGTGATTTGGATAATATAAATAGATATATTGAATTAGACGGTTACGAAATTGAGCAAAACATTATAATTGAAGGAAAAAAGTTAGGATTAACAGAAAGGCACTTTGATCAATTAATTTCTACTTTAAGTGGTGGTGAGCAAACAAAAGTTTCGTTTTTGAAAGTTAAATTAGATAAAGCACGATTATTATTAATTGATGAACCAACTAACCATATGGATGAAGAAATGAAAGTATGGTTAACTAATGCATTTAAACAAGAAAAACGTGCAATATTATTTGTTTCTCACGATAAGACTTTTTTAAATGAAACACCAGACGCAATTTTGGAACTGAGTAGTAGTGGTGCAACAAAATACTCAGGTCAGTATGACAATTACAAGCAACAAAAAGATTTAGAATATAAAACGATTAAGCTACAATACGAAAAACAAGAAAAAGAGCAACGAGCAATTGAAGAAACAATTAAAAAATATAAAGAATGGTATCAAAAAGCTTCACAAAAAGCTTCAGTAAGAAATCCTTATCAACAAAAACAACTTAGCAAGCTTGCGAAAAAGTTTAAATCGAAAGAATATCAAATGAATAAAAAACTTGAACAAACCAATTTATCAGATCCTGAAGAGGAAGGAAAAACATTTTCAATGCAACATCACGCCTTCAAATCTCATTATTTAGTTAAATTTAAAAATGTGACATTTTCATATAATGAAAAGCCTATTTTTAATGATGTCTCTTTTCATATTAAGCGAAATCAAAATGTTATCATTGAAGGTCAAAATGGCTCAGGTAAATCTACTTTGATCAAGTTGATACTAGGTCAACTGACACCTGATGAGGGAGAAGTAATCGTACATCCTGAATTAGAAATAGGTTATTTTTCACAAGATTTTAATAACTTAAATATGAAAAATACTGTGTTAGAAGAAATAATGTCTATTCAAGAAATGAAAGAAGCGGAAGCAAGAACAATTTTAGCGAATTATTATTTTAATGAAAATAGAATTAATGATGTTGTTGCCAATTTATCTATGGGTGAAAAATGTAGAATACAGTTTGTTAAATTGTATTTTTCAAATCCACATATACTCATATTAGATGAGCCAACTAACTATTTTGATATTGAAATGCAAGAAAAAATCATACAATTAATTCAATCTTTTCAAGGATCAACACTTATCATTTCACATGATAAATATTTTAAAGAAAAGCTTAAAGATCAAATTTGGACAATAAAGAATCTAGATTTGGTACATGAAAATCTTAAAATTGAGAATCCATTAAATGCTGATTCTATTAAAAATCAATTAAATGAATTAGAGCAATATACCGACGAAAGAAATAGAGAAACAGAGTTCTAG | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8690|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALD | ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8691|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALE | ATGTCTTTTTATTTTGCCCAAAAACCTTTTGAAATGTTTGGAAAAACACTGATTCAGTCAGTGGATTTACAATTTGAAAAGGGTGAACATATTGCTGTGATTGGTAATAATGGCGTTGGGAAAACGACTTTATTAAAAGCATTAAATAATAAGTATAAAGAAGATACTTATTTGATGGACCAAAACATGACTACCTTTGGAAACATGACGGGGATAGACTATGTAATAAGCTTAAACACAGAATTGTTTCATTTAAAACAAGCGTTAATGGATAACTATGAAAAAGTTTCAGATTATATCGCTTTAAATGGCTATGAATTTGAACAAACCATTATAACTAAAGCGAAGCAAATGGCTCTAACGGAAGCAGATCTTGACAAACCAATTAAAGTATTAAGCGGCGGCCAACAAACTAGGCTTGCTTTATTGAGAGCATTTATTTCAAACAAACCATTGATATTGCTGGACGAACCAACCAATCATTTAGACCAAGAAATGATAGACCAATTGATTAACCATATACAACAATCAAAACGCACAATCATATATGTGTCGCATCATAGAGGATTTATAGATCAGACCGCGAGTCATGTTATAGAAATAACACCCGAAAGTACAAGAAAATTTAATGGCAATTATAAGCAATACAAAGAGATAAAAGATTTAGAAAGTCAAACAGAACAACGTATATATAATAAACAACAAAAAGAAATACAAGACCTCGAACGTACGATCAAACGCGTACAAACATGGCATCATTCTGCTCAGCAAAAAGCAAGTGTACGTAATCCGATTGAACAGAAAAAGTTGAGCAAATTAGCGCAAAGGGCAAAGGTGAAGGAAAAACAATTAAACCAAAAATTACAAGAAAAACATATTCAAGAACCGAGTAAAGAAACAAAGTCATATTACTTTAGTCATCAGACTAGCCTTCCTAAACGTTTCTTAATTCGTTTTGAAGATGTTAGCGTTAATATTGATGGACAAGCTATATATAAACACGCTCATTTTGAAATGAAACAAAATGAAAATATATTACTTACTGGTCCAAATGGAAGTGGTAAATCGCTTTTCATCGCTTTGATTAGACAGCATTTATCACCAGACGAAGGTATTATAGAGATTACGCCATCGTTAAAGATAGGTTACTTTGATCATACAAATAACAATCTAAATGAAGCAGAATCTCCATTATCAATGTTGTTAGTAAGAACTAACATAACGCGTAGCCAAGCGCAGACATTACTTGCTTCATTTAATTTTGATAAGGATCAAATCAAAAAACCAATTCGCTATTTGTCTATGGGGGAAAAAAGTCGTTTACAATTTGTATTATTATATTTTTCAGGTGCTAATTTATTAGTATTGGATGAGCCTACGAACTATTTTGATATTGTAACTCAAGATTTAATTTTAAGTATGATTCAAAGTTTTACCGGTCAAGTATTGATTGTTACACATGATTCATATTTACAATCTCAATTTAAAGCTGTACATTGGGAAATAAAAAATCAACAACTTTATAATGTATCTTTAACTCATACGCGTGAATCAAACTTAGATGAAACCCTTAAGTTACTAGGTGAATATAAATTTATAGATGAAAATGGTCATTTTGAAACAGACAACTAG | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8083|Drugs|MLS|23S_rRNA_methyltransferases|ERM52 | ATGAAAAATCTTGGATATTCACAAAATTTTTTGGTTAATAAAAAGTTGGTAGAACGTTTAATAAGCAAGTCAAATATTGATGTAACAGATTATGTTATTGAAATTGGTCCTGGAAAAGGGATAATAACAGATGTACTTTCTCAGCATGCTGGAGAGGTTGTTGCAGTTGAATATGATCAAGAATTATATAATAATTTAGTAAGATATCACAGTCATGATAATGTTACATATATATTTGGTGATTTTTTAAAATATAAGTTGCCTTTAAATCGCAGATATAAAATATTCTCCAATATTCCTTTTCAGATAACAGCGGATATTATTAGGAAATTAACAGACGATGTAAATCCACCATCAGATATAAATATCATAATTCAAAGAGAGGCAGCTAAAAAGAATTGCGGTATTCCATTACAAAAATATGAAGGTTTTCGTGCTGCTATAATAAAGGCACAATATAAGGTAGAAATTACACATAGTTTTAAAAGGAGCGATTTTTTTCCTTCGCCTAATGTTGATACAGTTATGCTTCATATGCAGTTATGGGATGATAGATTGAGTGGTGATGATCTTCAAAATTATAAAGATTTAGTGGCTTTTTTTTACACTAATATTAAAGGAGAGACTGCTAAAGAGAGACTTTCTATTTTATTTTCTAATGAGCAAATCAAAAGATTGGGAAAAGCCAATAGAATTAGTCTTTCAAATTCATATACGTTAATCACGGCCGAGCAGTGGATGAATATTTATTATTACTCCAAAATTGGATTGACAGATGAAAAGAAAAAAAAGTTTCAAGATGCATATAAAAAACTTCAAAAAATGAATAAAAAATTGAAAAAGCAAAACAGAACATCTTTACGAAAGTCTAGTAGCAATAAGAAATGTAGAACAAGGATTGATACTTCTAATGGTACAAAAAATAGATAG | MLS | 23S rRNA methyltransferases | Drugs | 1 |
MEG_8259|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG | ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTATGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGTTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCAGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGATTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA | MLS | MLS resistance ABC efflux pumps | Drugs | 1 |
MEG_8262|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRL | ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG | MLS | MLS resistance ABC efflux pumps | Drugs | 1 |
MEG_8244|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF | ATGAATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGATTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG | MLS | MLS resistance MFS efflux pumps | Drugs | 1 |
MEG_8082|Drugs|MLS|23S_rRNA_methyltransferases|ERM51 | ATGCCTACCTACAGGCCGAACAAGGGCCGTCACGAGAACGGCCAGAACTACCTCGTCAACAAGTCAATGATTAAGAAGGTCGTTGACCTTGTCCCTGTCAGTGCGTCCGTCCCGGTCATAGAGATCGGCCCGGGACACGGGGCGCTGACCTTTCCCCTCCAGGACCGTGTCCTGGCTACCGGTGGATCGTTGACCGCCGTCGAGATCGACCCGGCCTCCGTCCGGTGGCTGGAGGAGCGGCTGCGCCCGGAGGTTCACCTGTACGAGCAGGACGTCCTTGATTTTGTGCTGCCGGACGGCCCGCACGTCCTGGTGGGGAACCTGCCGTTTCACCTGACCACCGCGATCCTGCGGCACGTCCTTCACTCACCGGGGTGGACTCACGCGGTCTTCCTGGTGCAGTGGGAGGTCGCGCGTCGCCGCGCCGGCGTCGGTGGTGCCACGATGATGACAGCCCAGTGGTGGCCCTGGTTCGACTTCGAACAGCACGGGCGAATACCATCCACACATTTCCGTCCCCGCCCCACCGTCGACGCCGGTGTCCTGGTGATGCGTCGCCGGGAAGAGCCTCTCGTCAACTGGTCGGAGCGTGCGCGGTACGCGTCGTTCGTCCATGCCGTGTTCACCGGCAAGGGCCGAGGCATCGCCGACATCGTGTCCCGGGTCGTGGGGCGTCGGCGTGAACGACGGTGTGCTGAGGTCCTGCGTGAGGCCGGTGTTCCGGCAAACGCACTGCCGAAACAGTTGGACGCGGGGCAGTGGGCCACACTGTTTAAGGCCGTGGGGCGCTAA | MLS | 23S rRNA methyltransferases | Drugs | 1 |
MEG_8246|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFJ | ATGGAAAACAACAAATGGAAGCAGAAGTTTTTTGCAATATATACAGGACAATTCTTTTCACTATTAAGTAGTGCGGCCGTTCAATTTGGTATTATTTGGTGGCTAACTGATAAAACTGGTGGTTCACCATTGCTTCTAACACTAGCAGGACTTGCAGGTTTTTTACCACAAGCATTAGTAGGACCTTTTGCTGGCACGATTACAGACCGTTATTCACGGAAGTTTTTGATGATTTCAGCAGATATGACTGTTGCGTTAGGTAGTTTAATTTTATTTTTAATATTGCATTTCTATGAGGCTAATATCATTTTTGTAATTCTGATTTTAGCACTTAGATCATTAGCAACTGCTTTTCATATGCCAGCAATGCAAGCATCAATTCCTTTACTTGCCCCTGAAGAAGCATTGACAAAGGTCGCTGGTTGGGGGCAAATGGTAGCATCCGTTTCTAATATAGTAGGACCAGCTGTAGGGATGTCAATTCTTTCAGTGAGCTCAATTAAATGGGTACTACTTTTAGATATACTTGGAGCTGTAGTTGCAAGTGGGATTTTACTTTTTATAAATATACCTAAAATACAAAAAACTGAATCTGTTGAACTTACAAGTTTTTTTGTAGAAATGAAAGAAGGGTATAATGCCCTTGTTAATCATCCTATCTTGTTGAAACTTACAATACTTATGACAATCGTAGCAGTCCTATACATACCACTTGGAACTTACTTCCCACTTATGACAAGAAATCATTTTGGGAAAGGTGTTGTTGAAGCTGGTACAGTAGAGATTGCATTTGCTATCGGTTTAATAGTAGGCGGTTCATTGTTAGGTATAATAGGTGATAAATTTGAAAAAGTGAAGACAATGGCAATTGGAATGCTATTGATGGGACTGGCACTATTTTTCTCTGGTCTTCTCTCACCATCACTTTTCTTTATCTTTATAATTTTGTCCGGATTGGTTGGATTTTCAGGACCTTTATTTTCTGCACCATTCTATGCTTATATTCAAACTGAGATTGAGCCACAATTATTAGGAAGAATTTTCAGTTTTGTAACAAGTCTCTCACTTTTAGCCACGCCAATTGGATATGCATTATCTGGTTTACTAATTGAATTTACTAGTGTTTCTATATTGTTTTCAATCATTGGTGTATTAGTAATACTAAGTGGTCTTATTACTTTAAAAGTGAAATAG | MLS | MLS resistance MFS efflux pumps | Drugs | 1 |
MEG_8724|Drugs|betalactams|Class_B_betalactamases|VAM | ATGAATTTTCTGATAAAAAATATTCTGCTCATTACTCTTTTTGTTCCTTTTGTAACAGCAGCAAACAATACAGACACTAAAACGCTGGAGGTTAAACAATTAACCGATAATATCTATCAGCATATCTCATATAAACATGTTGAGCCTTGGGGGTTTATTGGCGCGTCTGGCTTAATTGTAGTCGATGGAGATGCGGCATACCTGATTGACACTCCTTGGACGACCAAAGCAACCAATCAACTTATTGAATGGATTGAAGATAGAGGTCTCGTACTAAAAAGCGCAATAGTAACTCACTTTCATGAAGATGCGAGTGGTGATTTACCACTTTTAAATGATTTAAAAGTTAACACTTATGCCACTTCACTCACTAATCAACTTCTTAAACTCAATAACAAAGAAATTTCGAATACTGAAATATCGAGCAATGAACTCAAAATTTTCAACGGCATTGCGACAGTGTATTATCCTGGCCCAGGCCATACTGAAGATAACATCGTTGTTTGGTTACCGAATGAAAAGCTATTATTTGGCGGTTGCTTTGTTAAAAGCCTCCGTAATAAAAGTCTAGGTTACACTGGAGATGCAAATATAGGCGAATGGTCGAACTCTATTCAAAGAGTGCTGCAACGCTATCCAGATATAGTCACTGTAGTGCCTGGGCATGGTCAGGTTGGAGACGTTAGTTTACTCCTTCATACACAAAAATTAGCATCATCCGATAAGACTTCTGACAAATAG | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8236|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR | ATGATGCAGCATACTTCTGTGTGGTACCGACGCTCGGTCAGTCCGTTTGTTCTTGTGGCGAGTGTTGCCGTTTTCTTGACCGCGACCGCCAATCTTACCTTTTTTGATAAAATCAGCCAAACCTATCCCATCGCGGACAATCTCGGCTTTGTGCTGACGATCGCTGTCGTGCTCTTTGGCGCGATGCTACTGATCACCACGCTGTTATCATCGTATCGCTATGTGCTAAAGCCTGTGTTGATTTTGCTATTAATCATGGGCGCGGTGACCAGTTATTTTACTGACACTTATGGCACGGTCTATGATACGACCATGCTCCAAAATGCCCTACAGACCGACCAAGCCGAGACCAAGGATCTATTAAACGCAGCGTTTATCATGCGTATCATTGGTTTGGGTGTGCTACCAAGTTTGCTTGTGGCTTTTGTTAAGGTGGATTATCCGACTTGGGGCAAGGGTTTGATGCGCCGATTGGGCTTGATCGTGGCAAGTCTTGCGCTGATTTTACTGCCTGTGGTGGCGTTCAGCAGTCATTATGCCAGTTTCTTTCGCGTGCATAAGCCGCTGCGTAGCTATGTCAATCCGATCATGCCAATCTACTCGGTGGGTAAGCTTGCCAGTATTGGGTATAAAAAAGCCAGTGCGCCAAAAGATACCATTTATCACGCCAAAGACGCGGTACAAGCAACCAAGCCTGATATGCGTAAGCCACGCCTAGTGGTGTTCGTCGTCGGTGAGACGGCACGCGCCGATCATGTCAGCTTCAATGGCTATGAGCGCGATACTTTCCCACAGCTTGCCAAGATCGATGGCGTGACCAATTTTAGCAATGTCACATCGTGCGGCACATCGACGGCGTATTCTGTGCCGTGTATGTTCAGCTATCTGGGCGCGGATGAGTATGATGTCGATACCGCCAAATACCAAGAAAATGTGCTGGATACGCTGGATCGCTTGGGCGTAAGTATCTTGTGGCGTGATAATAATTCGGACTCAAAAGGCGTGATGGATAAGCTGCCAAAAGCGCAATTTGCCGATTATAAATCCGCGACCAACAACGCCATCTGCAACACCAATCCTTATAACGAATGCCGCGATGTCGGTATGCTCGTTGGCTTAGATGACTTTGTCGCTGCCAATAACGGCAAAGATATGCTGATCATGCTGCACCAAATGGGCAATCACGGGCCTGCGTATTTTAAGCGATATGATGAAAAGTTTGCCAAATTCACGCCAGTGTGTGAAGGTAATGAGCTTGCCAAGTGCGAACATCAGTCCTTGATCAATGCTTATGACAATGCCTTGCTTGCCACCGATGATTTCATCGCTCAAAGTATCCAGTGGCTGCAGACGCACAGCAATGCCTATGATGTCTCAATGCTGTATGTCAGCGATCATGGCGAAAGTCTGGGTGAGAACGGTGTCTATCTACATGGTATGCCAAATGCCTTTGCACCAAAAGAACAGCGCAGTGTGCCTGCATTTTTCTGGACGGATAAGCAAACTGGCATCACGCCAATGGCAACCGATACCGTCCTGACCCATGACGCGATCACGCCGACATTATTAAAGCTGTTTGATGTCACCGCGGACAAAGTCAAAGACCGCACCGCATTCATCCGCTGA | Lipopeptides | Colistin phosphoethanolamine transferase | Drugs | 1 |
MEG_8233|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|LSAD | ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8640|Drugs|betalactams|Class_C_betalactamases|PRC | ATGCGCCACCTGTACCGCCCTCTGTTCGTCGCCCTGGCGCTGCTGGCCGCCAGCCACGCGCCGGCCGCACCTTCACTGGAAACACAGGTGGACGCCGCTGCGAAGTCGATGATGCAGACCCATGCCATTCCCGGCATGGCCATCGCCATCAGCCACAAGGGGCAGTCGCATTTCTTCGAATACGGCGTCGCATCCCTTGAAAACGGCCAGACGGTGGATCGCCATACCCTTTTCGAGCTGGGCTCGATCAGCAAACTCTTCACCGCCACCCTCGGCGCCTACGCCGAAGCGCGCGGCACGCTGAACCTCAGTGACAACGCCAGCCAGTATCTGCCGGCCCTGCAGGGCAGCGCCTTCGATCACATCAGTTTGCTGGATCTGGCCACTTACACCTCGGGCGGCCTGCCACTGCAGTTCCCGGACACGGTCAGCAACGAACGGCAGATGCTCGATTACTACCGCAACTGGCAGGCGGTGTATCCGCCGGGTACGCAGCGGCTGTATTCCAACCCCAGCATCGGCCTGTTCGGCCACCTGGCAGCAGCCAGTCTGGCCAAGCCGTTTCAGCAGTTGATGGAGAAGGATCTGCTGCCGCAACTGAGCATGCAGGAAAGCTACGTCCGTATACCGACCGAGCAGATGGAGCACTATGCCTGGGGCTACCGCGACGACAAGGCGGTGCGCGTGACGCCCGGCGCGCTGGATGCCGAAGCCTACGGGTTGAAATCTACTGCCGCCGACGTGCTACGCTTCATCGACGCCAATCTGCACCCGGATCAACTACCCGCACCACTGCGCCAGGCGATCAGCGCAACACATCGTGGCTACTACCAGGTCGGCGACATGACTCAGGCGCTGGGCTGGGAGCGCTACGCCTACCCCATCAGCCTAGAAAAACTGCAGGCTGGCAACTCAGCAGAAATGGCGCTGCAACCGCAGACCGTGGCGCGTTTCGCTGCGCCCAAGCCTGCCGAAGGTGACCTGCTGCTGAACAAGACCGGCTCGACCAACGGCTTCGGCGCCTACATCCTACTGCTGCCGGCGCGCGATACCGGCCTGGTGATACTCGCCAACCGCAATTACCCCAATGCCGAACGCGTGCGCCTGGCCTTGCAATTGCTGGACGCGATCGAGCCGTAG | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8185|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8183|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCACTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8008|Drugs|betalactams|Class_A_betalactamases|BLAZ | ATGTTCGTTTTAAACAAGTTCTTTACCAATTCACATTACAAAAAAATTGTACCTGTCGTATTACTTTCATGCGCGACACTGATAGGGTGTTCTAATAGTAATACGCAATCAGAATCAACTAAACAAACAAATCAAACCAATCAAGTTAAGCAAGAAAATATAGGTAATCATGCTTTTGCTAAACTTGAAAAAGAATATAACGCTAAACTTGGTATTTACGCACTGGACACAAGTACGAATCAGACTGTTGCTTACCATGCAGATGATCGTTTTGCATTTGCCTCTACATCTAAATCATTAGCAGTGGGAGCTCTTTTACGTCAGAATTCAATAGAAGCTCTTGATGAAAGAATTACGTATACACGTGAAGACCTATCTAATTATAATCCAATTACTGAAATGCATGTGGATACAGGAATGACGTTAAAAGAACTTGCAGATGCTTCTGTTCGATATAGTGACAGTACGGCACATAATTTAATTCTTAAAAAGTTAGGTGGTCCATCCGCATTTGAAAAAATCTTGAGGAAAATGGGTGATACTGTTACTAACTCCGAGCGATTTGAACCTGAATTAAATGAAGTAAATCCAGGAGAAACACATGATACGAGTACACCAAAAGCAATCGCTAAGACGCTTCAATCTTTTACATTAGGAACTGTACTACCATCTGAGAAACGTGAACTGTTAGTAGATTGGATGAAGAGAAATACGACTGGGAATAAATTAATTCGTGCGGGTGTACCAAAAGGATGGGAAGTAGCTGATAAAACAGGTGCAGGATCTTATGGAACAAGGAATGATATCGCAATTATTTGGCCACCAAATAAAAAGCCGATTGTTCTTTCCATCCTTTCTAATCATGATAAAGAAGATGCAGAATACGATGATACACTTATTGCAGACGCTACGAAAATCGTGTTAGAAACTCTAAAAGTTACGAATAAATAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8184|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAACCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8667|Drugs|betalactams|Class_A_betalactamases|ROB | ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8668|Drugs|betalactams|Class_A_betalactamases|ROB | ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8153|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation | ATGGGTAAAAACGAGGCCAGAAGATCGGCCCTGGCGCCCGATCACGGTACAGTGGTGTGCGACCCCCTGCGGCGACTCAACCGCATGCACGCAACCCCTGAGGAGAGTATTCGGATCGTGGCTGCCCAGAAAAAGAAGGCCCAAGACGAATACGGCGCTGCGTCTATCACCATTCTCGAAGGGCTGGAGGCCGTCCGCAAACGTCCCGGCATGTACATTGGCTCGACCGGTGAGCGCGGTTTACACCATCTCATTTGGGAGGTGGTCGACAACGCGGTCGACGAGGCGATGGCCGGTTATGCAACCACAGTGAACGTAGTGCTGCTTGAGGATGGCGGTGTCGAGGTCGCCGACGACGGCCGCGGCATTCCGGTCGCCACCCACGCCTCCGGCATACCGACCGTCGACGTGGTGATGACACAACTACATGCCGGCGGCAAGTTCGACTCGGACGCGTATGCGATATCTGGTGGTCTGCACGGCGTCGGCGTGTCGGTGGTTAACGCGCTATCCACCCGGCTCGAAGTCGAGATCAAGCGCGACGGGTACGAGTGGTCTCAGGTTTATGAGAAGTCGGAACCCCTGGGCCTCAAGCAAGGGGCGCCGACCAAGAAGACGGGGTCAACGGTGCGGTTCTGGGCCGACCCCGCTGTTTTCGAAACCACGGAATACGACTTCGAAACCGTCGCCCGCCGGCTGCAAGAGATGGCGTTCCTCAACAAGGGGCTGACCATCAACCTGACCGACGAGAGGGTGACCCAAGACGAGGTCGTCGACGAAGTGGTCAGCGACGTCGCCGAGGCGCCGAAGTCGGCAAGTGAACGCGCAGCCGAATCCACTGCACCGCACAAAGTTAAGAGCCGCACCTTTCACTATCCGGGTGGCCTGGTGGACTTCGTGAAACACATCAACCGCACCAAGAACGCGATTCATAGCAGCATCGTGGATTTTTCCGGCAAGGGCACCGGGCACGAGGTGGAGATCGCGATGCAATGGAACGCCGGGTATTCGGAGTCGGTGCACACCTTCGCCAACACCATCAACACCCACGAGGGCGGCACCCACGAAGAGGGCTTCCGCAGCGCGCTGACGTCGGTGGTGAACAAGTACGCCAAGGACCGCAAGCTACTGAAGGACAAGGACCCCAACCTCACCGGTGACGATATCCGGGAAGGCCTGGCCGCTGTGATCTCGGTGAAGGTCAGCGAACCGCAGTTCGAGGGCCAGACCAAGACCAAGTTGGGCAACACCGAGGTCAAATCGTTTGTGCAGAAGGTCTGTAACGAACAGCTGACCCACTGGTTTGAAGCCAACCCCACCGACGCGAAAGTCGTTGTGAACAAGGCTGTGTCCTCGGCGCAAGCCCGTATCGCGGCACGTAAGGCACGAGAGTTGGTGCGGCGTAAGAGCGCCACCGACATCGGTGGATTGCCCGGCAAGCTGGCCGATTGCCGTTCCACGGATCCGCGCAAGTCCGAACTGTATGTCGTAGAAGGTGACTCGGCCGGCGGTTCTGCAAAAAGCGGTCGCGATTCGATGTTCCAGGCGATACTTCCGCTGCGCGGCAAGATCATCAATGTGGAGAAAGCGCGCATCGACCGGGTGCTAAAGAACACCGAAGTTCAGGCGATCATCACGGCGCTGGGCACCGGGATCCACGACGAGTTCGATATCGGCAAGCTGCGCTACCACAAGATCGTGCTGATGGCCGACGCCGATGTTGACGGCCAACATATTTCCACGCTGTTGTTGACGTTGTTGTTCCGGTTCATGCGGCCGCTCATCGAGAACGGGCATGTGTTTTTGGCACAACCGCCGCTGTACAAACTCAAGTGGCAGCGCAGTGACCCGGAATTCGCATACTCCGACCGCGAGCGCGACGGTCTGCTGGAGGCGGGGCTGAAGGCCGGGAAGAAGATCAACAAGGAAGACGGCATTCAGCGGTACAAGGGTCTAGGTGAAATGGACGCTAAGGAGTTGTGGGAGACCACCATGGATCCCTCGGTTCGTGTGTTGCGTCAAGTGACGCTGGACGACGCCGCCGCCGCCGACGAGTTGTTCTCCATCCTGATGGGCGAGGACGTCGACGCGCGGCGCAGCTTTATCACCCGCAACGCCAAGGATGTTCGGTTCCTGGATGTCTAA | Fluoroquinolones | Fluoroquinolone-resistant DNA topoisomerases | Drugs | 1 |
MEG_8287|Drugs|betalactams|Mutant_porin_proteins|OMP36|RequiresSNPConfirmation | ATGAAAGTTAAAGTACTGTCCCTCCTGGTACCAGCACTGCTGGTAGCGGGCGCAGCAAATGCGGCTGAAATTTATAACAAAGACGGCAACAAATTAGACCTGTACGGTAAAATCGACGGTCTGCACTACTTCTCTTCCGACGACAGCGTCGACGGCGACCAGACCTACATGCGTATCGGCGTGAAAGGCGAAACCCAGATCAACGACCAGCTGACCGGTTACGGCCAGTGGGAATACAACGTTCAGGCGAACAACACTGAAAGCTCCAGCGACCAGGCATGGACTCGTCTGGCCTTCGCGGGTCTGAAATTCGGCGACGCGGGTTCTTTCGACTACGGTCGTAACTACGGCGTTGTTTACGACGTAACTTCCTGGACCGACGTTCTGCCGGAATTCGGCGGCGACACCTACGGTTCCGACAACTTCCTGCAGTCCCGTGCTAACGGTGTTGCCACCTACCGTAACTCTGACTTCTTCGGTCTGGTTGACGGCCTGAACTTTGCTCTGCAGTACCAGGGTAAAAACGGCAGCGTGAGCGGCGAAGATCAGACCAACAACGGTCGTGACTTCCAGAAACAGAACGGCGAAGGCTTCGGCACCTCCGTAACTTATGATATCTGGGACGGCATCAGCGCTGGTTTCGCGTACTCCAGCTCTAAACGTACCGACGAGCAGAACAACTCTACCTTCGTGTCTAAGACCGATGGTGGTCGTTACGGTGTTCTGGGTGAAGGCGATCACGCTGAAACCTACACCGGTGGTCTGAAATACGACGCCAACAACATCTACCTGGCGACTCAGTACACCCAGACTTACAACGCAACCCGCACCGGTAACATCGGTTTTGCTAACAAAGCGCAGAACTTCGAAGTCGTTGCTCAGTACCAGTTCGACTTCGGTCTGCGTCCGTCCGTGGCTTACCTGCAGTCTAAAGGTAAAGACATGGGCCGTTACGGCGACCAGGACATCCTGAAATATGTTGACCTGGGTGCGACCTACTACTTCAACAAAAACATGTCCACCTACGTTGATTACAAAATCAACCTGCTGGACGACAACAAGTTCACTAAAGATGCAAGCATCTCTACTGACAACGTTGTGGCTCTGGGCCTGGTTTACCAGTTCTAA | betalactams | Mutant porin proteins | Drugs | 1 |
MEG_8448|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation | ATGACCAGCCTTGCGCATCATGCGACAGAAAACCGCTCTGTAGCCGAATTTACTGAACAGGCTTACTTGAATTATGCCATGTACGTCATTATGGACCGTGCATTGCCGCATATCAGTGATGGCTTAAAGCCCGTACAGCGCCGTATTGTCTATGCTATGAGCGAGCTAGGCTTAAAAAGCAGTGGCAAGCCAAAAAAATCAGCGCGTACAGTGGGTGATGTACTTGGTAAATACCACCCACATGGTGACTTGGCATGTTATGAAGCCATGGTACTCATGGCTCAGCCATTTAGTTACCGCTATCCTTTAATCGAAGGTCAGGGGAACTGGGGTTCACCAGATGATCCTAAATCTTTTGCTGCGATGCGTTATACCGAAGCCAAACTCTCGGCTTATAGTGAATTATTGCTGAGCGAATTAGGTCAGGGCACTAGCGAATGGCAAGATAACTTTGATGGTTCTTTAAAAGAACCGATCACTTTACCTGCACGTGTACCTAATATTCTTCTTAATGGTACGACAGGTATTGCTGTCGGGATGGCAACTGATATCCCGCCACATAATTTGCGTGAAGTTGTAAAAGGCACAATTGCTTTAATCCGTAATCCGCAAACCTCGGACGAAAAATTAGCTGAATATATTCCGGCTCCGGATTTACCAACCAAAGCTGAAATTATTACCCCGCCAGAAGAATTACTCAAAATCCAGACCACTGGTCGTGGTAGTTACCGTATGCGAGCGGTATATACCATTGAGAAAAATGAAATCGTAATTACTGAGCTGCCATATCAAGTCTCTGGTTCTAAGGTAATTACTCAAATTGCTGACCAGATGCAGGCTAAAAAGCTGCCATTAGTCGTTGATGTGCGTGATGAATCGGATCATGAAAACCCGACACGACTCGTGATTGTACTGCGCTCTAACCGTATTGATGCGGAAGCAGTAATGAGTCACTTATTTGCGACCACCGATTTAGAATCAAGCTATCGTGTCAATTTAAACATGATTGGCGAAGATGGCCGTCCTCAGGTGAAATCAATTCGTCGTATTTTGCTTGAATGGATCGAGATCCGTAAAAAAACGGTAACTCGTCGTTTGCAGTACCATTTAAACCGTATTGAAAAGCGCCTGCATATTTTGGCAGGTCTTTTAATTGCTTATCTCGATATTGATACAGTCATTCGTATTATTCGTGAAGAAGACCAGCCTAAGCCAGTCTTGATGGAACACTTTAATATTGATGAGATACAGGCCGAGGCGATTTTAGAGCTTAAATTACGTCATTTGGCAAAGCTTGAAGAGATGGAAATTCGTCATGAACAAGATGAGCTTTCCGCGAAAGCTGCCATTATTCGTGAACAACTCGAAAATCCTGAATCTTTAAAAAATTTGATTATTGGCGAATTAAAAGAAGATGCGAAAAAGTTCGGTGATGAGCGCCGTTCTCCAATTGTTGCACGTGCTGAAGCGGTTCAAATTAAAGAACAGGATTTAATGCCAGCTGAAACGGTAACAGTCGTGTTGTCTGAAGCAGGCTGGGTTCGTGCGGCAAAAGGTGCGGATGTGGATGCTGAAAATCTGAACTACCGTGCTGGGGACCAATATTTAAGTCATGCTGTCGGGAAAACCAATCAGCGAGTTTACTTCCTTGATGAAACAGGGCGCAGCTATGCCTTGCCAATTAGTAACTTACCTTCAGCGAGAGGCTTGGGGGATCCATTAAGTTCTAAATTATCACCAGCAAGTGGCGTATCGTTTATTCAGGTTTATTTAGATGATGATGAGTCTGAGTTGATTGCTGCAAGTTCGGCAGGTTATGGTTTTAAAACGCAAACCAAGCAATTAGATACCAATGCGAAAGCCGGTAAGACATTCTTAACGGTTCCGGATAAGGCAAAGGCTTTACCACTTATTTCTGCCCAAAACATGACGCATTTGGCTGTACTGAGCTCAGCAGGGCGTTTGTTAATTTTAGATTTGGCAGAACTACCAAATTTAAATAAAGGTAAAGGTAATAAGTTGATACAACTTGAAGGCAAAGAGCAAATTTTATCCATGACAACCCTGAACTTAGATGAAATAATTCAGGTGGTTGCAGGTCAACAACATCTCAAATTAAAAGGTGATGATCTACAAAAATACATGGGTAAACGTGCTTCGAAAGGTCAGCTCTTACCACGTGGATATCAAAAAGCAAATAAACTGTTGATTCAGAGATAA | Fluoroquinolones | Fluoroquinolone-resistant DNA topoisomerases | Drugs | 1 |
MEG_8148|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation | ATGGATCAATTCGCCAAAGAGACCCTGCCCACCTCCCTCGAGGAGGAAATGCGCCGTTCGTATCTCGATTACGCGATGAGCGTGATCGTCGGACGTGCCCTTCCGGATGTCCGCGATGGCCTGAAGCCCGTGCACCGGCGCGTACTGTTCGCGATGCACGAACTGAACAACGACTGGAACCGCGCGTACAAGAAATCGGCGCGTATCGTCGGCGACGTGATCGGTAAGTACCACCCGCACGGCGACACGGCGGTCTACGACACGATCGTGCGGATGGCGCAGGACTTCTCGCTGCGCTACATGCTGATCGACGGGCAGGGCAACTTCGGCTCGATCGACGGCGACAATGCGGCGGCGATGCGGTACACCGAAATTCGCATGGCGAAGATCGGGCACGAGCTGCTCGCCGACATCGACAAGGAAACGGTCGATTTCGAGCCGAACTACGACGGCAACGAAACGCAGCCGTCGGTCCTGCCGTCGCGGATCCCGAACCTGCTGATCAACGGCTCGTCGGGCATCGCCGTCGGCATGGCGACCAACATTCCGCCGCACAACCTGAACGAAGTCGTCGACGCGTGCCAGCACCTGCTGAGCAACCCCGACGCGACGGTCGACGAACTGATCGAGATCATCCCGGCGCCGGATTTCCCGACGGCCGGCATCATCTACGGCGTCGCCGGCGTGCGCGACGGCTACCGCACCGGCCGCGGCCGCGTCGTGATGCGCGCGGCCACGCACTTCGAGGAGATCGACCGCGGCCAGCGGATGGCGATCATCGTCGACGAGCTGCCGTACCAGGTCAACAAGCGCTCGCTGCTCGAGCGGATCGCCGAGCTCGTCAACGAGAAGAAGCTCGAAGGCATTTCCGATATCCGCGACGAATCCGACAAGAGCGGCATGCGGGTCGTGATCGAGCTCAAGCGCGGCGAAGTGCCGGAAGTGGTGCTGAACAACCTGTACAAGGCGACGCAGCTGCAGGACACGTTCGGCATGAACATGGTCGCGCTCGTCGACGGCCAGCCGAAGCTGCTGAACCTGAAGGAAATCCTGCAGTGCTTCCTGTCGCACCGGCGCGAAGTGCTGACGCGCCGCACGATCTACGAACTGCGCAAGGCGCGCGAGCGCGGCCACGTGCTCGAAGGTCTCGCGGTCGCGCTCGCGAACATCGACGAGTTCATCGCGATCATCAAGGCCGCGCCGACGCCGCCGATCGCGAAGCAGGAGCTGATGACGAAGTCGTGGGATTCGTCGCTCGTACGCGAGATGCTGACGCGCGCCGAATCCGAGAACGCGGCGGCGGGCGGCCGTGCCGCGTACCGTCCGGAAGGGCTGAATCCGGCGTACGGGATGCAGGCCGACGGGCTGTACAGGTTGTCCGACACGCAGGCGCAGGAAATCCTGCAGATGCGTCTGCAGCGCCTGACCGGCCTCGAGCAGGACAAGATCATCGGCGAGTATCGCGAAGTGATGGCGCAGATCGCCGATCTGCTCGACATCCTCGCGCGCCCGGAGCGCATCACGACGATGATCGGCGACGAGCTGACGACGGTGAAGGCCGAATTCGGCGATGCGCGCCGCTCGCGGATCGAGCTGAACGCGACCGAACTGAATACCGAAGACCTGATCACGCCGCAGGACATGGTCGTCACGATGTCGCATGCCGGCTACGTGAAGTCGCAGCCGCTGTCGGAGTACCGCGCGCAGAAGCGCGGCGGCCGCGGCAAGCAGGCGACGCAGATGAAGGAAGACGACTGGATCGAGACGCTCTTCATCGCGAATACGCACGACTACATGCTGTGCTTCTCGAACCGCGGTCGCGTGTACTGGATCAAGGTCTACGAGGTGCCGCAAGGTTCGCGCAACTCGCGCGGCCGTCCGATCGTCAACATGTTCCCGCTGCAGGAAGGCGAGAAGATCAACGTCGTGCTGCCGGTGAAGGAATTCTCGGCCGACAAGTTCGTGTTCATGGCGACGTCGCTCGGCACGGTCAAGAAGACGCCGCTCGAAGCGTTCAGCCGTCCGATGAAGAAGGGCATCATCGCGGTCGGCCTCGACGAGGGCGACTATCTGATCGGCGCGTCGATCACCGACGGCGCGCACGACGTGATGCTGTTCTCCGATTCGGGCAAGGCCGTGCGCTTCGACGAGAACGACGTGCGTCCGATGGGCCGCGAAGCGCGCGGCGTGCGCGGCATGCAGCTCGAGGACGGGCAGCAGGTCATCGCGCTGCTGGTCGCGGGCAGCGAGGAGCAGTCCGTGCTCACCGCAACCGAGAACGGCTTCGGCAAGCGTACGCCGATCACCGAGTACACGCGTCACGGCCGCGGCACGAAGGGTATGATCGCGATCCAGACCTCCGAGCGTAACGGCAAGGTCGTCGCTGCGACGCTCGTCGATCCGGAAGATCAGATCATGCTGATCACGACGGCCGGCGTGTTGATTCGCACGCGCGTTTCCGAGATCCGCGAGATGGGACGGGCGACGCAAGGTGTTACACTCATCAGTCTCGATGAGGGTACGAAGCTTTCGGGTCTGCAGCAGATTGCCGAGGCCGAAGAGGGCGATGGCGAAGCCGACGAGGCGTCGGACGGCGAAGCCTGA | Fluoroquinolones | Fluoroquinolone-resistant DNA topoisomerases | Drugs | 1 |
MEG_8455|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation | ATGATTAAAAAGATTTTAACGACTTGTTTTGGTTTGGTTTTTGGGTTTTGTGTATTTGGAGTGGGTTTGGTTGCCATTGCTATTTTGGTAACGTATCCGAAACTGCCGTCTTTGGATTCTTTGCAGCATTACCAGCCTAAAATGCCGTTGACTATTTATTCGGCGGATGGGGAAGTCATCGGTATGTATGGGGAGCAGCGGCGCGAATTTACAAAAATCGGCGATTTCCCAGAGGTGTTGCGGAATGCGGTTATCGCCGCCGAGGATAAACGCTTTTACCGGCATTGGGGGGTGGATGTTTGGGGTGTTGCCCGCGCTGCCGTCGGCAATGTCGTGTCCGGCAGCGTGCAGTCGGGTGCGAGTACGATTACGCAGCAGGTGGCGAAAAATTTTTATTTGAGCAGTGAAAAAACGTTCACACGCAAATTCAATGAGGTGTTGCTTGCCTATAAAATCGAGCAGTCTTTAAGCAAAGACAAAATCCTCGAGTTGTATTTCAATCAGATTTACCTCGGTCAGCGCGCCTATGGTTTTGCATCTGCCGCGCAAATCTATTTCAATAAGAATGTCCGAGATTTGACTTTGGCGGAAGCCGCCATGCTTGCGGGACTGCCCAAGGCTCCGTCTGCCTATAATCCGATTGTTAATCCAGAACGTGCCAAGTTGCGCCAGAAGTATATTTTGAACAATATGCTCGAGGAGAAGATGATTACCGTGCAACAGCGCGATCAGGCGTTGAATGAGGAACTGCATTACGAGCGGTTTGTTCGGAAAATCGATCAGAGTGCTTTATATGTGGCGGAAATGGTGCGTCAGGAACTGTATGAGAAATACGGTGAAGATGCCTATACGCAGGGTTTTAAGGTTTATACCACGGTCCGCGCCGATCATCAGAAGGTGGCAACCGAGGCATTGCGCAAGGCTCTACGGAATTTCGATCGCGGCAGCAGCTACCGCGGTGCGGAAAACTATATCGATTTGAGTAAGAGTGAAGATGTCGAGGAGACTGTCAGCCAGTATCTGTCGGGACTCTATACCGTCGATAAAATGGTTCCCGCCGTTGTGTTGGATGTGACTAAAAAGAAAAATGTCGTCATACAGCTGCCCGGCGGCAGGCGGGTTACGCTTGACAGGCGCGCCTTGGGTTTTGCGGCCCGCGCGGTCAATAATGAAAAAATGGGGGAGGACCGTATCCGCAGGGGCGCGGTCATCCGTGTCAAAAACAACGGCGGGCGTTGGGCGGTGGTTCAAGAGCCGTTGCTGCAGGGGGCTTTGGTTTCGCTGGATGCAAAAACCGGAGCTGTGCGCGCGCTGGTCGGCGGTTATGATTTTCACAGCAAAACATTCAATCGTGCCGTTCAGGCAATGCGGCAGCCGGGTTCGACCTTTAAGCCGTTTGTCTATTCGGCGGCATTATCTAAGGGGATGACCGCGTCCACAGTGGTTAACGATGCGCCGATTTCCCTGCCGGGGAAAGGGCCGAACGGTTCGGTTTGGACACCTAAAAATTCAGACGGCAGATATTCCGGCTACATTACTTTGAGACAGGCTCTGACGGCTTCCAAGAATATGGTTTCCATCCGTATTTTGATGTCTATCGGTGTCGGTTACGCGCAACAGTATATCCGGCGTTTCGGCTTCAGGTCGTCCGAGCTGCCGGCAAGCCTGTCTATGGCTTTAGGTACGGGCGAGACAACGCCGTTGAAAGTGGCGGAGGCATATAGCGTATTTGCGAACGGCGGATATAGGGTTTCTTCGCACGTAATCGATAAGATTTATGACAGAGACGGCAGGTTGCGCGCCCAAATGCAACCTTTGGTGGCCGGGCAAAATGCGCCTCAGGCAATCGATCCGCGCAATGCCTATATTATGTATAAGATTATGCAGGATGTGGTCCGTGTTGGTACGGCAAGGGGGGCAGCTGCGTTGGGAAGAACGGATATTGCCGGTAAAACGGGTACGACCAATGACAATAAGGATGCGTGGTTTGTCGGTTTTAACCCTGATGTGGTTACTGCCGTATATATCGGCTTCGACAAACCTAAGAGTATGGGGCGTGTCGGCTACGGCGGTACGATTGCGGTGCCGGTTTGGGTGGACTATATGCGTTTTGCGTTGAAAGGAAAGCAGGGCAAGGGGATGAAAATGCCTGAAGGTGTGGTCAGCAGCAATGGCGAATACTATATGAAGGAACGTATGGTAACCGATCCGGGCTTGACGCTGGACAACAGCGGTATTGCGCCGCAACCTTCCCGACGGGCAAAAGAAGATGACGGGGGCGCGGCAGAAGGCGGACGGCAGGCGGCGGATGACGAAGTCCGCCAAGATATGCAGGAAACGCCGGTGCTTCCGAGTAATACTGGTTCCAAACAGCAGCAGTTGGATTCCCTGTTTTAA | betalactams | Penicillin binding protein | Drugs | 1 |
MEG_8633|Drugs|betalactams|Penicillin_binding_protein|PILQ|RequiresSNPConfirmation | ATGAATACCAAACTGACAAAAATCATTTCCGGTCTCTTTGTCGCAACCGCCGCCTTTCAGACGGCATCGGCAGGAAACATTACAGACATCAAAGTTTCCTCCCTGCCCAACAAACAGAAAATCGTCAAAGTCAGCTTTGACAAAGAGATTGTCAACCCGACCGGCTTCGTAACCTCCTCACCGGCCCGCATCGCCTTGGACTTTGAACAAACCGGCATTTCCATGGATCAACAGGTACTCGAATATGCCGATCCTCTGTTGAGCAAAATCAGTGCCGCACAAAACAGCAGCCGTGCGCGTCTGGTTCTGAATTTGAACAAACCGGGCCAATACAATACCGAAGTACGCGGGAACAAAGTTTGGATATTCATTAACGAATCGGACGATACCGTGTCCGCCCCCGCCCGCCCAGCCGTAAAAGCCGCGCCTGCCGCACCGGCAAAACAACAGGCTGCCGCACCGTTTACCGAGTCCGTAGTATCCGTATCCGCACCGTTCAGCCCGGCAAAACAACAGGCAGCGGCATCGGCAAAACAACAGGCGGCGACACCGGCAAAACAAACCAATATCGATTTCCGCAAAGACGGCAAAAATGCCGGCATTATCGAATTGGCGGCATTGGGCTTTGCCGGGCAGCCCGACATCAGCCAACAGCACGACCACATCATCGTTACGCTGAAAAACCATACCCTGCCGACCGCGCTCCAACGCAGTTTGGATGTGGCAGACTTCAAAACACCGGTTCAAAAGGTTACGCTGAAACGCCTCAATAACGACACCCAGCTGATTATCACAACAACCGGCAACTGGGAACTCGTCAACAAATCCGCCGCGCCCGGATACTTTACCTTCCAAGTCCTGCCGAAAAAACAAAACCTCGAGTCAGGCGGCGTGAACAATGCGCCCAAAACCTTCACAGGCCGGAAAATCTCCCTTGACTTCCAAGATGTCGAAATCCGCACCATCCTGCAGATTTTGGCAAAAGAATCCGGGATGAACATTGTTGCCAGCGACTCCGTCAACGGCAAAATGACCCTCTCCCTCAAAGATGTGCCTTGGGATCAGGCTTTGGATTTGGTTATGCAGGCGCGCAACCTCGATATGCGCCAGCAAGGGAACATCGTCAACATCGCGCCCCGCGACGAGCTGCTTGCCAAAGACAAAGCCTTCTTACAGGCGGAAAAAGACATTGCCGATCTGGGCGCGCTGTATTCCCAAAACTTCCAATTGAAATACAAAAATGTGGAAGAATTCCGCAGCATCCTGCGTTTGGACAATGCCGACACGACCGGAAACCGCAACACGCTTGTCAGCGGCAGGGGCAGCGTGCTGATCGATCCCGCCACCAACACCCTGATTGTTACCGATACCCGCAGCGTCATCGAAAAATTCCGCAAACTGATTGACGAATTGGACGTACCCGCGCAACAAGTGATGATTGAGGCGCGTATCGTCGAAGCGGCAGACGGCTTCTCGCGCGATTTGGGCGTTAAGTTCGGCGCGACAGGCAGGAAAAAACTGAAAAATGAGACGAGCGCATTCGGCTGGGGCGTGAACTCCGGCTTCGGGGGCGGCGATAAATGGGAGGCCCAAACCAAAATCAACCTGCCGGTTGCCGCTGCCGCAAACAGCATTTCGCTGGTGCGCGCGATTTCCTCCGGCGCGTTGAATTTGGAATTGTCCGCATCCGAGTCGCTTTCAAAAACCAAAACGCTTGCCAATCCGCGCGTGCTGACCCAAAACCGCAAAGAGGCCAAAATCGAATCCGGTTACGAAATTCCTTTTACCGTAACTACAGCCTCGGGCGGCGGCAACTCTACCAACACGGAACTCAAAAAAGCCGTCTTGGGGCTGACCGTTACGCCGAACATCACGCCCGACGGACAAATCATCATGACCGTCAAAATCAACAAAGACTCGCCTGCACAATGTGCTTCAGGCAACAACACAATCCTATGTATTTCGACCAAAAGCCTGAATACGCAGGCTATGGTTGAAAACGGCGGCACTTTGATTGTCGGCGGTATTTATGAAGAAAACAACGGCAATACGCTGACCAAAGTCCCCCTGTTGGGCGACATCCCCGTTATCGGCAACCTCTTTAAAACACGCGGGAAAAAAACCGACCGCCGCGAACTGCTGATTTTCATTACCCCGAGGATTATAGATACGGCCGGCAACAGCCTGCGCTATTGA | betalactams | Penicillin binding protein | Drugs | 1 |
MEG_8149|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation | ATGCAAGATAATTCAGTCAATGAAACAAAAAATATTGTAGAAGTGGGGATTGATTCTTCTATTGAAGAGAGCTATTTAGCTTATTCCATGAGCGTGATCATAGGGCGCGCTTTACCGGACGCTAGAGATGGCTTAAAGCCCGTGCATAGGCGTATTTTGTATGCGATGCATGAATTAGGCCTTACTTCAAAAGTCGCTTACAAAAAAAGCGCTAGGATCGTGGGTGATGTGATTGGTAAATACCACCCCCATGGCGATAATGCGGTTTATGATGCGCTAGTGAGAATGGCGCAAGATTTTTCCATGCGTTTGGAATTAGTGGATGGGCAGGGCAACTTTGGCTCTATTGATGGCGATAACGCCGCAGCGATGCGTTACACTGAAGCCAGAATGACTAAGGCGAGTGAAGAAATTTTAAGGGATATTGATAAAGACACCATTGATTTTGTGCCTAATTATGACGATACCTTAAAAGAGCCAGATATTTTACCAAGCCGTCTGCCTAACCTTTTAGTCAATGGGGCTAATGGGATCGCTGTGGGGATGGCGACTTCTATCCCCCCTCACAGGATGGATGAAATCATAGACGCTTTAGTGCATGTCTTAGAAAACCCTAACGCTGGATTAGATGAAATCTTAGAATTTGTCAAAGGGCCTGATTTTCCCACTGGTGGGATCATTTATGGCAAGGCGGGTATTATTGAAGCCTATAAAACGGGGCGAGGACGCGTGAAAGTGCGGGCCAAAGTGCATGTGGAAAAAACAAAAAATAAAGAAATCATCGTTTTAGATGAAATGCCTTTTCAAACCAATAAAGCCAAATTAGTGGAACAAATCAGCGATTTAGCGCGAGAAAAGCAAATTGAAGGCATTAGTGAAGTGCGCGATGAGAGCGATAGAGAGGGCATTAGAGTGGTGATTGAATTAAAAAGAGACGCGATGAGTGAAATTGTCTTAAACCACCTCTACAAACTCACCACTATGGAAACCACTTTTAGCATCATTTTACTCGCTATTTACAATAAAGAGCCTAAGATTTTCACGCTTTTAGAGTTGTTGCACCTTTTCTTAAACCACAGAAAAACCATTATTATAAGACGCACGATTTTTGAATTAGAAAAGGCTAAGGCCAGAGCGCATATTTTAGAGGGCTATTTGATCGCACTAGACAATATTGATGAAATCGTGCGACTCATTAAAACAAGCCAAAGCCCAGAAGCGGCTAAAAACGCCTTAATGGAGCGTTTCACTTTGAGCGAGATTCAAAGCAAGGCCATTTTAGAAATGCGTTTGCAACGCTTAACAGGCCTTGAAAGGGATAAGATCAAAGAAGAATACCAAAACTTGTTGGAGCTTATTGATGATCTCAATGGCATTTTAAAGAGCGAAGATCGCTTGAATGGAGTCGTCAAAACAGAGCTTTTAGAAGTCAAAGAGCAATTTTCTTCTCCAAGGCGCACTGAAATTCAAGAATCTTATGAAAATATTGACATAGAAGATTTGATCGCTAATGAGCCTATGGTAGTGAGCATGAGTTATAAAGGCTATGTGAAAAGAGTGGATTTAAAAGCTTATGAAAAGCAAAATCGTGGTGGTAAAGGCAAGCTTTCAGGCAGCACTTATGAAGACGATTTCATTGAAAACTTTTTTGTGGCTAACACGCATGATATTTTGCTCTTTATCACCAATAAGGGGCAATTGTATCATTTGAAAGTCTATAAAATCCCAGAAGCGAGCCGGATCGCTATGGGTAAAGCCATTGTAAATTTAATCTCGCTCGCTCCGGATGAAAAGATCATGGCGACTCTAAGCACCAAAGACTTTAGCGATGAACGCTCTTTGGCCTTCTTCACGAAAAATGGCGTGGTGAAGCGCACCAATTTGAGCGAATTTGAAAGCAACAGGAGTTGTGGTATCAGAGCGATTGTTTTAGATGAAGGCGATGAATTAGTGAGCGCAAAAGTTGTGGATAAAAACGCTAAGCATTTGCTCATCGCATCGCATTTGGGCATTTTCATTAAATTCCCTTTAGAAGAGGTGCGCGAGATCGGAAGAACTACTCGTGGGGTTATAGGCATCAAGCTGAATGAAAACGATTTTGTTGTCGGTGCGGTCGTTATTAGCGATGATGGCAACAAGCTTTTGAGCGTGAGTGAAAACGGGCTTGGCAAGCAAACTTTAGCCGAAGCGTATAGAGGGCAATCTCGTGGAGGTAAGGGGGTCATTGGCATGAAGCTCACTCAAAAAACCGGCAATCTAGTGGGCGTTATCAGCGTGGATGATGAAAATTTGGATTTGATGATCCTTACTGCAAGCGCAAAAATGATCAGAGTTTCTATTAAAGATATTAGAGAAACCGGAAGAAACGCTAGTGGGGTAAAGCTCATAAACACCGCCGATAAAGTCATGTATGTCAATTCTTGCCCTAAAGAAGAAGAGCCAGAAAATTTAGAAACCTCTTCGGCACAAAATTTGTTTGAGTGA | Fluoroquinolones | Fluoroquinolone-resistant DNA topoisomerases | Drugs | 1 |
MEG_8152|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation | ATGCAAAATTACCAGAGCCATAGTATTAAGGTTTTAAAAGGCTTAGAGGGGGTTAGGAAACGCCCTGGAATGTATATTGGTGATACCAATGTGGGTGGGTTGCACCACATGGTGTATGAAGTCGTGGATAACGCTGTAGATGAGAGCATGGCGGGTTTTTGCGATACGATTAATATCACTTTGACCGATGAGGGTTCATGCATCGTAGAAGATAACGGGCGAGGCATTCCTGTAGATATTCACCCCACGGAAAAAATCCCCGCTTGCACCGTGGTTTTAACGATTTTGCATGCGGGGGGCAAGTTTGATAACGATACTTATAAAGTTTCAGGCGGTTTGCATGGCGTGGGCGTTTCGGTTGTGAACGCTTTGAGCAAACGCTTGATTATGACCATTAAAAAAGAGGGTCAAATTTATCGCCAAGAGTTTGAAAAGGGTATTCCTACTAGCGAGCTTGAAATCATTGGCAAAACCAAAAGCGCTAAAGAAAGCGGCACGACTATTGAATTTTTCCCTGATGAAAGCGTGATGGAAGTCGTTGAATTTCAAGCGGGTATTTTACAAAAACGCTTTAAAGAAATGGCGTATCTTAACGATGGCTTAAAAATTTCTTTCAAAGAAGAAAAAACCCAACTGCAAGAGACTTATTTCTATGAAGACGGCTTGAAACAATTCGTTAAAGACAGCGCTAAAAAAGAATTGCTCACCCCCATTATTTCGTTTAAAAGCATGGATGAAGAAACGCGCACTTCTATAGAAGTCGCTCTAGCGTATGCTGATGATTATAATGAAAACACTTTAAGCTTTGTGAATAACATTAAAACTTCTGAAGGTGGCACGCATGAGGCGGGCTTTAAAATGGGCTTGTCTAAAGCAATTTTGCAATATATTGGCAATAATATTAAAACCAAAGAGTCACGCCCCATCTCTGAAGATATTAAAGAGGGGTTGATCGCTGTTGTGAGCTTGAAAATGAGCGAGCCTTTGTTTGAAGGGCAGACTAAATCCAAACTCGGCAGTTCGTATGCGCGCGCGTTGGTTTCAAAATTAGTCTATGATAAAATCCATCAATTTTTAGAAGAAAACCCTAACGAAGCCAAAATCATTGCCAATAAAGCCCTACTAGCTGCAAAAGCCAGAGAAGCCAGTAAGAAAGCCAGAGAGCTTACAAGGAAAAAAGATAATTTGAGTGTCGGCACTTTGCCTGGAAAATTAGCCGATTGCCAGAGTAAAGACCCCTTAGAGAGTGAAATCTTTTTAGTGGAGGGCGATAGTGCGGGCGGGAGCGCTAAACAAGGGCGCGATAGGGTTTTCCAAGCGATCTTGCCCCTAAAAGGTAAGATTTTAAATGTGGAAAAAAGCCATTTATCAAAAATCCTAAAATCAGAAGAAATTAAAAACATGATCACGGCTTTTGGGTGCGGCATTCAAGAGAGTTTTGATATAGAAAGATTGCGCTATCATAAAATCATTATCATGACCGATGCTGATGTGGATGGGAGCCATATCCAAACCTTGCTGATGACTTTTTTCTATCGTTATTTGCGCCCGCTGATTGAACAAGGGCATGTTTATATCGCTCAAGCCCCTCTTTACAAATACAAGAAGGGCAAGACAGAAATTTATCTTAAAGACAGCGTCGCTTTGGATCATTTTTTAATTGAGCATGGCATCAATTCGGTGGATATTGAAGGGATTGGCAAGAACGATTTGATGAACTTGTTAAAAGTGGCACGCCATTACCGCTATGCGCTTTTGGAATTAGAAAAACGCTACAATTTGCTAGAAATTTTACGCTTTCTCATTGAAACTAAGGACGCCTTAAGCCTTGATATGAAAGTTTTAGAAAAAAGCATTTTAGAAAAATTAGAGGGCTTGAATTATCAGATCTTACGCTCTTTTGCCACTGAAGAAAGCTTACATTTGCACACGCAAACCCCTAAAGGCTTGGTGGAATTTAACCTAGATGACAATCTCTTTAAAGAAGTGTTGTTTGAAGAAGCGAATTACACTTACCAAAAGCTTATGGAGTATAATTTAGACTTCTTAGAAAATAAGGATATTTTGGCGTTTTTAGAAGAAGTGGAAAATCACGCTAAAAAGGGAGCGAATATCCAGCGCTATAAGGGGCTAGGCGAGATGAACCCTAATGATTTGTGGGAAACGACCATGCATAAAGAAAACCGCAGCTTGATCAAACTCAAAATTGAAGATTTAGAAAAAACCGATGCAGTCTTTTCGCTTTGCATGGGCGATGAAGTAGAGCCTAGAAGAGCCTTTATCCAAGCGCATGCTAAAGATGTGAAACAACTAGATGTGTAA | Fluoroquinolones | Fluoroquinolone-resistant DNA topoisomerases | Drugs | 1 |
MEG_8458|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation | ATGGATAATAAAAACATTGATCCCAACTTCAACCCAGAACGATTTTTAGAAACCCAAAAATACAAGGGCTCTATTACGGCTTTAATCTTTTTATTGCTTTTTTTTATTTTTTTAATGGTGGCTTTTAAAAAAGCTTTTTTTGCCCAAGCCAACATGCCTAATCTAGTGATGAGCAAACAAGACACTGCGGCTAGGGGGACTATCTATAGTCAAGACAACTACAGCCTAGCCGCTTCGCAAACCCTTTTCAAACTGGGCTTTGATACAAGGTTTTTAAACCCGGATAAAGAAGATTTTTTCATTGATTTCCTTTCTATTTATAGCAATATCCCTAAAAAGTCCTTAAAAGACGCCATCAATACGAAAGGCTATATTATTCTAGCCTATGATCTCACGCCCAATATGGCCGCTAACATTAGAGACTTGAATAAGAAATTTTTAGCCTTTGGGGTTTTTCAAAATTTCAAAGACGCGCACGATAAGGTGTGGCAAAAGCAAGGGCTAAACATTGAAGTGAGCGGCGTTTCCAGGCATTACCCTTATCAAAATAGCCTAGAGCCAATCATTGGCTATGTGCAAAAACAAGAAGAAGACAAGCTCACTTTAACTACCGGTAAAAAAGGCGTTGAAAAATCTCAAGATCACTTGCTTAAAGCCCAACAAAATGGCATAAGAACAGGCAAAAGAGATGTGAGTTTTAATTTTATTCAAAACCACTCTTACACAGAGGTTGAGCGCCTTGATGGCTATGAGGTGTATTTGAGCATTCCTTTAAAACTCCAAAGAGAAATTGAAACCCTATTGGATAAAACCAAAGACAAACTCAAGGCTAAAGAAATCCTAGTGGGTATCATTAACCCTAAAAGCGGGGAAATCTTATCGCTAGCTTCAAGCAAGCGCTTCAATCCTAACGCCATTAAAACCAGCGATTATGAAAGCTTGAATTTGAGCGTTGCCGAAAAGGTTTTTGAGCCAGGCAGCACGATCAAACCCATTGTTTATTCCTTGCTGTTAGACAAGAATTTGATCAACCCTAAAGAACGCATTGATTTAAACCATGGCTATTACCAATTAGGAAAATACACCATTAAAGACGACTTTATCCCTAGTAAAAAAGCCGTTGTGGAAGATATTTTGATCCAATCTAGCAATGTGGGCATGATAAAAATCAGCAAAAATCTCAACCCGGAGGATTTCTATAATGGGCTTTTAGGCTATGGATTTTCTCAAAAAACCGGCATTGATTTATCCTTAGAAGCCACAGGAAAGATCCCTCCTTTGTCCGCTTTCAAGCGTGAAGTGTTAAAGGGGAGCGTCTCTTATGGCTATGGGCTGAACGCGACTTTTTTGCAGCTTTTAAGGGCTTATGCGGTGTTTTCTAATGAAGGCAAATTGACTACCCCCTATTTAGTGCAACGAGAGACCGCCCCTAATGGCGATATTTACATCCCTAGCCCCAAACCCACTTTTCAAGTCATTAGCCCCAAAAGCGCCAGGAAAATGAAAGAAACCTTAATCAAAGTGGTGCGTTATGGCACAGGCAAAAACGCTCAATTTGAAGGGTTATACATAGGGGGCAAAACAGGCACGGCTAGGGTTGCTAAAAACGGGAGTTACAGCGCGGAATCCTACAACAGCTCTTTTTTTGGGTTCGCTGAAGATGAAAGGCAGGTTTTTACTATCGGCGTGGTTATCTTAGGCTCGCACGGCAAGGAAGAATATTATGCTAGCAAGATTGCAGCCCCTATTTTTAAAGAAATCACCGAAATTTTAGTGCGTTACAATTACCTATCGCCCTCTATTGCGATTCAAAACGTGCTCGAGAAAAACCGCTTTAAGATAAAATAA | betalactams | Penicillin binding protein | Drugs | 1 |
MEG_8457|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation | ATGAAAAATCTTCGCTATAAGCTTTTGCTCTTTGTTTTTATAGGGTTTTGGGGGTTATTGGTTTTAAATTTATTTATTTTAAGCGTTAAAAATCAAGAATACTATGAAAAATTGGCCGAACGCAACATGACCAAAAAGGAATTTCTAGTCCCTACAAGGGGCGATATTACAGACAGAAATGATGAGTTTTTAGCCACTAACGAATTGGTGTTTGGCGTGTTTTTGCCTAGTAGACTGAAACAAAAAGAACTTTTGGAAAAAATTGAAATCATCCAAAAGTTTTTCCCTAACTTTTCCAAAGAAACGCTTTTAAACAATTACCAAAAAGAAAATTCGCTTTATAACCACAACCTCATTAAAGTGGTGGGATTCATTCCTTATATCGCCATGCAACCTCTTTATGCCAAACTCATCCAAACTCAAGGCATTTTTGCTCTTCCCTTAGACAAGCGCTACTACCCTAATAACGCTTTAGCTTCACATGTTTTAGGCTATGTGGGGGTGGCAAGCTTGCAAGATCTAAAAGACGATGAAGAAAATCAATACAGCCAGATTGTAGGCAAAACCGGCATTGAAAAAGAATATAACAAGCTTTTACAAGGCAAGGTGGGCTATAAAATCATGCGTGTCAATGCACTCAATCAAGAATTAGCCACTTTAGAAGTAGTGCCGCCAAGCACCAACAACCACTTGCAATTGAGTTTAGACAAACGCTTGCAAAAAGAAGCGGACAAGCTCTTTGAAAATAAGAGAGGGGCTATTTTAGTGATGAACGCAGAAAATGGGGAATTGCTCGTTGCAGGAAGTTACCCTGAATACAATTTGAACGATTTTGTAGGCGGGATCAGTCAAGACAAATGGCAAAAACTTCAAGATGATATTTATAACCCCTTATTAAACCGCTTCGCTAACGCTTTGTATCCGCCGGGATCTGTGGTTAAAATGGGCGTGGGCTTGAGCTTTTTAGAAAACCTTCATATCACAGAAAACACCACCATACCCACCCCGCCTTTTATTGAAGTGGGCAAGCGCAAATTCAGGGACTGGAAAAAAACAGGGCATGGCAATTCTAATTTGTATAAAGCGATTAGGGAGTCCGTGGATGTGTATTTTTATAAGTTTGGGCTTGAAATCTCTATAGAAAAACTCTCTAAAACCTTAAGAGAAGTGGGCTTTGGGGAAAAAACAGGCGTTGATTTGCCGAATGAATTTGTGGGGATTGTGCCGGATAATTTGTGGAAACTCAAACGATTCAATCAAGATTGGCGCGTTGGGGACACGCTCATTACTGCTATTGGGCAAGGCTCTTTTTTAGCCACGCCCTTACAAGTGCTAGCCTATACGGGACTCATTGCGACAGGCAAACTGGCAACGCCTCATTTTGCTATCAATAATAAACAGCCGCTCAAAGACCCCCTGAATAGTTTTCAAAAAAAGAAGCTCCAAGCCTTGCGCGTGGGCATGTATGAAGTGTGTAACCATAAAGACGGCACCGCTTATCATTCCACAAGGGGTTCTAAGGTTACTTTAGCGTGTAAAACCGGCACCGCGCAAGTCGTGGAAATCGCTCAAAACATCGTCAATCGCATGAAAGAAAAGGATATGGAGTATTTCCATCGATCCCATGCGTGGATTACCGCATTTTTGCCTTATGAAAAACCCAAATACGCTATCACTATTTTAGTAGAACATGGGGAAGGGGGGTCAAAACTAGGGGGCTTGTTAGTGAAAATGAGCAATAAACTCTATGAGCTTGGCTATCTTTAA | betalactams | Penicillin binding protein | Drugs | 1 |
MEG_8454|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation | ATGCTAAAAAAGATTTTTTATGGTTTTATCGTTTTATTTTTGATTATCGTAGGGTTGTTAGCCATTCTTATCGCTCAAGTTTGGGTAACTACGGATAAGGATATTGCTAAAATTAAAGATTATCGCCCGGGCGTCGCTTCACAGATTTTAGACCGAAAAGGGCGTTTGATCGCTAATATCTATGATAAGGAATTTCGTTTTTATGCGCGTTTTGAAGAAATCCCCCCACGATTTATTGAAAGCCTTTTAGCGGTAGAAGACACCCTCTTTTTTGAACATGGGGGGATCAATTTAGACGCTATCATGCGCGCTATGATTAAAAACGCTAAAAGCGGTCGTTACACCGAGGGGGGTAGCACCCTAACCCAACAACTCGTTAAAAACATGGTGCTCACACGAGAAAAAACCCTAACCAGAAAACTCAAAGAAGCTATCATTTCCATACGCATTGAAAAAGTCTTAAGCAAAGAAGAAATTTTAGAGCGCTATTTGAACCAAACTTTTTTTGGGCATGGGTATTATGGCGTGAAAACCGCAAGTTTAGGGTATTTTAAAAAACCCCTTGACAAACTCACGCTTAAAGAAATCGCCATGTTAGTCGCCTTGCCTAGGGCTCCGAGTTTTTATGATCCTACCAAAAATTTAGAATTTTCACTTTCTAGGGCTAATGATATTTTAAGGCGGTTGTATTCTTTAGGCTGGATTTCTTCTAACGAGCTCAAATCCGCTCTCAATGAAGTGCCAATCGTCTATAACCAAACTTCCACGCAAAATATCGCTCCCTATGTCGTGGATGAAGTATTGAAGCAATTGGATCAATTAGACGGGTTAAAAACTCAAGGCTATATTATAAAGCTCACGATAGATTTGGATTACCAACGCTTAGCGTTAGAGTCCTTGCGTTTTGGGCATCAAAAAATCTTAGAAAAAATCGCTAAAGAAAAGCCAAAAACTAACGCGTCTAATGAAGATGAAGACAACTTGAACGCTAGCATGATAGTTACAGACACGAGCACCGGTAAGATTTTAGCTTTAGTGGGAGGGATTGATTATAAAAAAAGCGCTTTCAATCGCGCCACGCAAGCCAAACGGCAATTTGGGAGCGCGATCAAGCCTTTTGTGTATCAAATCGCTTTTGATAATGGCTATTCCACGACTTCTAAAATCCCTGATACCGCGCGAAACTTTGAAAATGGCAATTATAGTAAAAACAGCAAACAAAACCATGCATGGCACCCCAGCAATTATTCTCGCAAGTTTTTAGGGCTTGTAACCTTGCAAGAAGCTTTGAGCCATTCATTAAATCTAGCCACGATCAATTTAAGCGATCAGCTTGGCTTTGAAAAAATTTATCAATCTTTAAGCGATATGGGGTTTAAAAACCTCCCTAAAGACTTGTCTATTGTGTTAGGGAGCTTTGCTATCTCACCCATTGAAGCGGCTGAAAAGTATTCTTTATTTTCTAATTACGGCACTATGCTCAAACCCATGCTCATTGAAAGCATCACTAACCAACAAAACGATGTCAAAACTTTCACGCCTATGGAAACCAAAAAGATCACCTCCAAAGAACAGGCTTTTTTAACCATTTCAGTGCTGATGAATGCGGTAGAAAACGGCACAGGGAGTTTGGCTCACATTAAAGGTTTAGAAGTCGCCGGTAAAACCGGAACTTCTAACAACAATATTGACGCTTGGTTCATTGGCTTTACCCCCACCTTGCAAAGCGTGATCTGGTTTGGGAGGGACGATAACACGCCTATTAGCAAAGGAGCGACAGGAGGCGTTGTGAGCGCGCCTGTGTATTCGTATTTCATGCGTAATATTCTAAGCATTGAACCTTCTTTAAAAAGAAAGTTTGATGTCCCCAAAGGCTTGCGTAAAGAAATTGTGGATAAAATCCCCTACTATTCAACCCCCAATTCCATCACCCCCACCCCCAAAAGAACAGACGATAGCGAAGAACGCTTGTTGTTCTAA | betalactams | Penicillin binding protein | Drugs | 1 |
MEG_8671|Drugs|MLS|Macrolide-resistant_50S_rRNA_mutation|RPLD|RequiresSNPConfirmation | ATGGAATTGAAAGTAATTGACGCTAAAGGACAAGTTTCAGGCAGCCTGTCTGTTTCTGATGCTTTGTTCGCCCGCGAATACAATGAAGCGTTGGTTCACCAGCTGGTAAATGCCTACTTGGCAAACGCCCGCTCTGGTAACCGTGCTCAAAAAACCCGTGCCGAAGTAAAACACTCAACCAAAAAACCATGGCGTCAAAAAGGTACCGGCCGCGCCCGTTCCGGTATGACTTCTTCTCCGCTGTGGCGTAAAGGCGGTCGCGCGTTCCCGAACAAACCCGACGAAAACTTCACTCAAAAAGTAAACCGTAAAATGTACCGTGCCGGTATGGCGACTATCCTGTCCCAATTGGCGCGTGACGAGCGTTTGTTTGTGATTGAGGCGTTGACTGCCGAAACTCCCAAAACCAAAGTTTTTGCCGAACAAGTAAAAAATTTGGCTCTGGAGCAAGTGCTGTTTGTAACCAAACGGCTCGACGAGAATGTTTACTTGGCTTCACGCAACTTGCCAAACGTATTGGTTTTGGAAGCTCAACAAGTTGATCCTTACAGCTTGCTGCGTTATAAAAAAGTAATCATCACTAAAGATGCGGTTGCACAATTAGAGGAGCAATGGGTATGA | MLS | Macrolide-resistant 50S rRNA mutation | Drugs | 1 |
MEG_8254|Drugs|MLS|Macrolide-resistant_23S_rRNA_mutation|MLS23S|RequiresSNPConfirmation | TGAAATGATAGAGTCAAGTGAATAAGTGCATCAGGCGGATGCCTTGGCGATGATAGGCGACGAAGGACGTGTAAGCCTGCGAAAAGCGCGGGGGAGCTGGCAATAAAGCAATGATCCCGCGGTGTCCGAATGGGGAAACCCACTGCATTCTGTGCAGTATCCTAAGTTGAATACATAGGCTTAGAGAAGCGAACCCGGAGAACTGAACCATCTAAGTACCCGGAGGAAAAGAAATCAACCGAGATTCCGCAAGTAGTGGCGAGCGAACGCGGAGGAGCCTGTACGTAATAACTGTCGAGGTAGAAGAACAAGCTGGGAAGCTTGACCATAGCGGGTGACAGTCCCGTATTCGAAATCTCAACAGCGGTACTAAGCGTACGAAAAGTAGGGCGGGACACGTGAAATCCTGTCTGAATATGGGGGGACCATCCTCCAAGGCTAAATACTCATCATCGACCGATAGTGAACCAGTACCGTGAGGGAAAGGCGAAAAGAACCCCGGGAGGGGAGTGAAACAGAACCTGAAACCTGATGCATACAAACAGTGGGAGCGCCCTAGTGGTGTGACTGCGTACCTTTTGTATAATGGGTCAACGACTTACATTCAGTAGCGAGCTTAACCGGATAGGGGAGGCGTAGGGAAACCGAGTCTTAATAGGGCGATGAGTTGCTGGGTGTAGACCCGAAACCGAGTGATCTATCCATGGCCAGGTTGAAGGTGCCGTAACAGGTACTGGAGGACCGAACCCACGCATGTTGCAAAATGCGGGGATGAGCTGTGGGTAGGGGTGAAAGGCTAAACAAACTCGGAGATAGCTGGTTCTCCCCGAAAACTATTTAGGTAGTGCCTCGAGCAAGACACTGATGGGGGTAAAGCACTGTTATGGCTAGGGGGTTATTGCAACTTACCAACCCATGGCAAACTCAGAATACCATCAAGTGGTTCCTCGGGAGACAGACAGCGGGTGCTAACGTCCGTTGTCAAGAGGGAAACAACCCAGACCGCCGGCTAAGGTCCCAAATGATAGATTAAGTGGTAAACGAAGTGGGAAGGCACAGACAGCCAGGATGTTGGCTTAGAAGCAGCCATCATTTAAAGAAAGCGTAATAGCTCACTGGTCGAGTCGTCCTGCGCGGAAGATGTAACGGGGCTCAAATCTATAACCGAAGCTGCGGATGCCGGTTTACCGGCATGGTAGGGGAGCGTTCTGTAGGCTGATGAAGGTGCATTGTAAAGTGTGCTGGAGGTATCAGAAGTGCGAATGTTGACATGAGTAGCGATAAAGCGGGTGAAAAGCCCGCTCGCCGAAAGCCCAAGGTTTCCTACGCAACGTTCATCGGCGTAGGGTGAGTCGGCCCCTAAGGCGAGGCAGAAATGCGTAGTCGATGGGAAACAGGTTAATATTCCTGTACTTGATTCAAATGCGATGTGGGGACGGAGAAGGTTAGGTTGGCAAGCTGTTGGAATAGCTTGTTTAAGCCGGTAGGTGGAAGACTTAGGCAAATCCGGGTTTTCTTAACACCGAAGAAGTGATGACGAGTGTTTACGGACACGAAGCAACCGATACCACGCTTCCAGGAAAAGCCACTAAGCTTCAGTTTGAATCGAACCGTACCGCAAACCGACACAGGTGGGCAGGATGAGAATTCTAAGGCGCTTGAGAGAACTCGGGAGAAGGAACTCGGCAAATTGATACCGTAACTTCGGGAGAAGGTATGCCCTCTAAGGTTAAGGACTTGCTCCGTAAGCCCCGGAGGGTCGCAGAGAATAGGTGGCTGCGACTTGTTTATTAAAAACACGAGCACTCTTGCCAACACGAAAGTGGACGTATAGGGTGTAACGCCTGCCCGGTGCCGGAAGGTTAATTGAAGATGTGCAAGCATCGGATCGAAGCCCCGGTAAACGGCGGCCGTAACTATAACGGTCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCCGCACGAATGGCGTAACGATGGCCACACTGTCTCCTCCCGAGACTCAGCGAAGTTGAAGTGGTTGTGAAGATGCAATCTACCCGCTGCTAGACGGAAAGACCCCGTGAACCTTTACTGTAGCTTTGCATTGGACTTTGAAGTCACTTGTGTAGGATAGGTGGAAGGCTTGGAAGCAAAGACGCCAGTCTCTGTGGAGTCGTCCTTGAAAATACCACCCTGGTGTCTTTGAGGTTCTAACCCAGACCCGTCATCCGGGTCGGGGACCGTGCATGGTAGGCAGTTTGACTGGGGCGGTCTCCTCCCAAAGCGTAACGGAGGAGTTCGAAGGTTACCTAGGTCCGGTCGGAAATCGGACTGATAGTGCAATGGCAAAAGGTAGCTTAACTGCGAGACCGACAAGTCGGGCAGGTGCGAAAGCAGGACATAGTGATCCGGTGGTTCTGTATGGAAGGGCCATCGCTCAACGGATAAAAGGTACTCCGGGGATAACAGGCTTGATTCCGCCCAAGAGTTCATATCGACGGCGGAGTTTGGCACCTCGATGTCGGCTCATCACATCCTGGGGCTGTAGTCGGTCCCAAGGGTATGGCTGTTCGCCATTTTAAAGTGGTACGTGAGTTGGGTTTAAAACGTCGTGAGACAGTTTGGTCCCTATCTGCAGTGGGCGTTGGAAGTTTGACGGGGGCTGCTCCTAGTACGAGAGGACCGGAGTGGACGAACCTCTGGTGTACCGGTTGTAACGCCAGTTGCATAGCCGGGTAGCTAAGTTCGGAAGAGATAAGCGCTGAAAGCATCTAAGCGCGAAACTCGCCTGAAGATGAGACTTCCCTTGCGGTTTAACCGCACTAAAGGGTCGTTCGAGACCAGGACGTTGATAGGTGGGGTGTGGAAGCGCGGTAACGCGTGAAGCTAACCCATACTAATTGCCCGTGAGGCTTGACTCT | MLS | Macrolide-resistant 23S rRNA mutation | Drugs | 1 |
MEG_8020|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML | ATGCCTTTTGATAACAAACAAACTCCACGCTGGAGTTATTCCCTGCCATTTGCGCTCGCGTTGATGGCTCCCTTCGACATTCTCGCCTCGCTGGCCATGGACATCTACTTGCCGGTCGTACCGTCCATGCCTGCGATCCTGCAAACGACACCCGCCATGGTGCAGCTGACGCTCAGCCTCTACATGGTGATGCTGGGTGTCGGGCAGCTTCTTTTCGGCCCGTTGTCCGACCGTTTCGGACGCAGGCCCATCCTGCTTGGCGGTGGACTGGTGTTCGCCCTTTCGTCCTTCGCTCTGGCGATTACCGACAATGCCACCGTTTTCGTATTGCTTCGTTTCGTACAGGCAACAGGTGCCTCGGCAGCACTTGTCGCCACTTTCGCAACGGTCCGCGACGTCTATGCGACGCGCCCCGAAGGCGCGACGATCTACGGCCTTTTCAGCGCCATGGTTTCCTTCGTCCCTGCGCTTGGGCCGATTGCAGGCGCCCTGATTGCAAAAGGGTTCGGATGGCGGACAATCTTCGCATTGCTGGGCGTTTTCAGTCTCGTCGCAACATGGCGCGCCTTGCGCCACTGGCACGAGACACGACCGACCAGCAGCGCGCCGGGCACAGGCGGTCTGGGGCGGATCATGAAGGATTTTCCCTTCTGGACCTATACGCTCGGTTTTGCGACGGCGATGGGCACGTTCTTCGTGTTCTTTTCCACCGCACCGCGCATTCTGATCGAACGCGGCGGTTTCCCGGAAACCGGCTTCAGTCTTGCCTTCGCAAGCGTTGCCATCGTCATGATCGCCGCCACGTGCATCCTGCCTCGCCATACGCAGAAATGGGGTGCCCGTAAAAGCGTGGCCCTTGGCATGACCGTGCTCCTTGCCAGCGCGCTCCTGCTTCTGGCGGGTGAGAAACTACTACAACCATCGTTCACAAGCCTCATCGTCCCGATGTGGCTTGCTGCTGTCGGGATTGTTTTCACTGCATCGATGACGGCAAATGGAGCGCTTGCAGCCTTTGATGACAATGCAGGCATGGCGGTCGCAGTCTATTTCTGCATTCAAAGCCTGATCGTCAGTCTCGCAGGAACCGCACTGGTCATTTTCCTGCCGGGCGATACTGCCTGGCCATTGATCGTTTTCTGCACAATCATGCCATTGCTGGTTCTGGCCATGCTCGTGAGGCTACGAAAGAACTGA | Phenicol | Phenicol resistance MFS efflux pumps | Drugs | 1 |
MEG_8013|Drugs|Phenicol|Chloramphenicol_acetyltransferases|CATA | ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTCTGTGATGGCTTCCATGTCGGCAGAATACTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA | Phenicol | Chloramphenicol acetyltransferases | Drugs | 1 |
MEG_8436|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCGTAGAACCCGGGTCCTCGTGTTGAGTTTTACACTCCTCCTGGCTTTACTGGCAGCTTGCAACCCACTCCAGACCGCCACGTCCCAACCCTTGCCGAACACAACCGTTCAGACGGAAACCGACCTTCCGGTTTCCGAAGAAAAACCGGAACTGGAAAATTTCTTCGAGGGAATGAAGGGCGCCTTTGTGTTGTACGACTTGAATGGTCAGAAAACGATCCGTTTCAATACACAGCGCTGCGCCGAACCCTTCCTGCCGGCGTCCACCTTCAAAATTCTAAACGCCCTAATTGGTTTGGAGACCGGCGTTATCTCGGACGAAAATTACAAGATTGCGTGGGACGGCACGAACTACGAGATCGCCTCCTGGAATCAGGATCAGACCCTCGCGACGGCGTTCCAAAATTCGGTCGTCTGGTATTACCAGGAACTCGCCCGGCGCGTCGGGGAAGAGAGAATGCGGCATTATGTGGAATTGGCCGATTATGGCAACCGGGACATCTCTGGCAAGATCGATACATTCTGGCTGGAAGGCGGCCTTCGAATATCAGCCGACCAACAGGTGGATTTTCTGAAGCGGTTCTATCAAAATGATCTGCCGTTTTCCACCTCATCGATCGACATCGTGAAGAAGATCATGATTTTGGAGTCGACCGATTCCTATACCTTTCGCGGAAAAACCGGATCGGTTCAACGTGTTCCCATCCACACCGGCTGGTTCGTGGGTTACCTGGAACGGGATGGGAATGTGTATTTCTTCGCGACCAACATTGAAAGCACCGATCCGGATGGATTTGCAAGCGGTGCGGCCGCGAGGGAAATTACAGAGAATATCCTGGTCGAGGAGGGTCTGCTGCCGCCCCGCTGA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8415|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTCCCGCCTGCTTCTCTCCAGCCTGCTGGCTGCCGGTCTGCTCGCCGCTCTGCCTGCCTCCGCCGCCAGCGGCTGTTTTCTCTATGCTGACGGCAACGGCCAGACCCTCTCCAGCGAAGGGGACTGCTCCAGCCAGCTGCCGCCCGCATCCACCTTCAAGATCCCGCTGGCACTGATGGGCTATGACAGCGGCTTTCTGGTGGATGAAGAGCATCCAGCACTGCCCTTCAAACCGGGTTACGACGACTGGCTGCCCGCCTGGCGCGAAACCACTACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAATACGTCGACCGCTTCGACTACGGCAACCGGGATCTCTCCGGCAATCCGGGCAAGCATGACGGCCTGACCCAGGCCTGGCTAAGCTCCAGCCTCGCCATAAGCCCGGAGGAGCAGGCCCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTCTCGGCGCAGACCCTGCAGTACACCGCCAATATCCTCAAGGTGAGCGAGATCGATGGCTGGCAAATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAACCGGGCAAGCAGCTGATCTTCGTCCATACCGTGGTGCAAAAGCCCGGCAAGCAGTTCGCCTCCCTCAAGGCGAAAGAAGAGGTGCTGGCCGCCCTGCCCGGGAAGCTGAAGACCCTGTAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8005|Drugs|betalactams|Class_B_betalactamases|BLAB | ATTATGAAGAATATAATGCGGGCACTGATCCTTGTTTTTGGTTTTATGAGTTTTTTTATGTTTGGACAGGAGAATCCTGACGTCAAAATTGAAAAGCTAAGAGATAATCTGTATGTATACACAACCTACAATACATTTAACGGGACTAAATATGCCGCTAATGCAGTATATCTGGTAACTGATAAGGGTGTTGTGGTTATAGACTGTCCGTGGGGAGAAGACAAATTTAAAAGCTTTACGGACGAGATTTATAAAAAACACGGAAAGAAAGTTATTATGAATATTGCAACACATTCTCATGATGATCGTGCCGGAGGTCTTGAATATTTTGGTAAAATAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCACAATATACTTTTGACAATAATAAATCTTTCAAAGTAGGAAAATCCGAGTTTCAGGTTTACTATCCCGGAAAAGGACATACAGCAGATAATGTGGTGGTATGGTTTCCAAAAGAAAAAGTATTGGTTGGAGGTTGTATTATAAAAAGCGCTGATTCAAAAGACCTGGGGTATATTGGAGAAGCATATGTAAATGACTGGACGCAGTCTGTACACAATATTCAACAGAAGTTTTCCGGTGCTCAGTACGTTGTTGCGGGGCATGATGATTGGAAAGATCAAAGATCAATACAACGTACACTAGACTTAATCAATGAATATCAACAAAAACAAAAGGCTTCAAATTAA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_7870|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC3-PRIME | ATGAGCATCATTGCAACCGTCAAGATCGGCCCTGACGAAATTTCAGCCATGAGGGCTGTGCTCGATCTCTTCGGCAAAGAGTTTGAGGACATTCCAACCTACTCTGATCGCCAGCCGACCAATGAGTATCTTGCCAATCTTCTGCACAGCGAGACGTTCATCGCGCTCGCTGCTTTTGACCGCGGAACAGCAATAGGTGGGCTCGCCGCCTACGTTCTACCCAAGTTCGAGCAAGCGCGAAGCGAGATCTACATTTATGACTTGGCAGTCGCTTCCAGCCATCGAAGGCTAGGAGTCGCAACTGCCCTGATTAGCCACCTGAAGCGTGTGGCGGTTGAACTTGGCGCGTATGTAATCTATGTGCAAGCAGACTACGGTGACGATCCGGCAGTCGCTCTCTACACAAAGCTTGGAGTTCGGGAAGACGTCATGCACTTCGACATTGATCCAGGAACCGCCACCTAA | Aminoglycosides | Aminoglycoside N-acetyltransferases | Drugs | 1 |
MEG_8006|Drugs|betalactams|Class_B_betalactamases|BLAB | ATAATGAAAGGATTAAAAGGGCTATTGGTTCTGGCTTTAGGCTTTACAGGACTACAGGTTTTTGGGCAACAGAACCCTGATATTAAAATTGAAAAATTAAAAGATAATTTATACGTCTATACAACCTATAATACCTTCAAAGGAACTAAATATGCGGCTAATGCGGTATATATGGTAACCGATAAAGGAGTAGTGGTGATAGACTCTCCATGGGGAGAAGATAAATTTAAAAGTTTTACAGACGAGATTTATAAAAAGCACGGAAAGAAAGTCATCATGAACATTGCTACACATTCTCATGACGATAGAGCCGGAGGTCTTGAATATTTTGGTAAACTAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCAAAGTACACTTTTGATAATAATAAATCTTTTAAAGTAGGAAACACTGAGTTCCAGGTCTATTATCCGGGAAAAGGTCATACAGCAGATAATGTGGTGGTATGGTTCCCTAAAGACAAAGTATTAGTAGGAGGCTGCATTGTAAAAAGCGGTGATTCGAAAGACCTTGGGTTTATTGGGGAAGCTTATGTAAACGACTGGACACAGTCCATACACAACATTCAGCAGAAATTTCCCGATGTTCAGTATGTCGTTGCAGGTCATGACGACTGGAAAGATCAAACATCAATACAACATACACTGGATTTAATCAGTGAATATCAACAAAAACAAAAGGCTTCAAATTAA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8441|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACGTTGCTAGGTTGCCAAAATTTGCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATACTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACATTTCAAGAATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAAGTTCGCCCAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATACTGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCCGTTGACGAAGTGAAATTTGCTTATGCTCTGGCAAATAAGCAGCTTGCATTTGACCAATCTGTGCAAGAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGTATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTGCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8721|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|TOPR | ATGACCTCTCACTTCATGCTCCGTCGCGCTCTGCTGCCCCTGGCCATCGCCGCCCTGGCGGGTTGTTCGCTGGCCCCGACCTACGAGCGCCCGCAGGCACCGGTCGCGTCGCACTGGCAAGCCGCCGACGCGGAGGGCACCCGTGCCCAGGCGCTGGACTGGCAGACCTTCATCGTCGATGCCGACTTGCGCCGCGCGGTGGATACGGCGCTGAGCAACAACCGCAGCCTGCGCCAGGCGCTGCTGGATATCGAAGCTGCGCGTGCCCAGTACCGCATCCAGCGTGCTGATCGCCTGCCTTCGATCAACGCCAATGCCAGCGGCAACCGCCAGCGCCTGCCTGCCGATCTGTCGCAGACCGGGCGCTCGGAAGTGACCAGCAACTATCAGGTCGGCCTCGGCCTCGCGGAGTACGAAGTCGACCTGTTCGGCCGCGTGCGCAACCTCTCCGAGGCCGCGCTGGAGACCTACCTGGCGACCGAGGAGGCGACCCGTGCCACGCAGATCAGCCTGGTTGCCGAGGTCATCCAGGCCTACCTGACCCGCGATGGTGCGCTACGCCGCATGGCCCTGGTCGAACAAACCCTGGACAGCCGCATGGCCTCGCTGGAGCTGGTCAGCCAGCGCCGTGCAGCGGGGGCCGCCACCGCCCTGGATTACCAGGAAGCGGTCGGCCTTGCCGAACAGGCTAGGGCCGAGCGCGAGAGCACCGAACGCCAGTTACGCCAGGCGGACAACGCCCTGGTCCTGTTGCTCGGCACGCCAGATGCCGCTCGCCTGCTGCCCGCGACGCCCCGCGACGACCTGATGGTGCTGCAGGACATCGCCCCCGGCACCAGCTCGGAACTGATCGAACGGCGCCCGGACATTCTCGCCAGCGAGCACCGCCTCAAGGCGCGCAATGCCGATATCGGTGCAGCTCGCGCCGCGTTCTTTCCCCGGATCAGCCTGACCGGTTCGGTGGGCAGCTCCAGTGCCGAGTTGTCCGGATTGTTCGATGGCGGCTCGCGGGCCTGGAGCTTTGCCCCGACGCTGTCGCTGCCGATCTTCGCCGGTGGCCGCAACCGCGCCAACCTGGACCTCGCCGAAGTGCGCCAGGACGCGGCGGTGGCCGACTACGAAGGCACCATCCAGACCGCCTTCCGCGAAGTGGCCGATGCCCTGGCCGCCACCGACACCCTGCGCCGCGAGGAGGCTGCCCGCCAGGCTCTGGCCGGTTCCAGCGAGGCTGCGATGGCCCTGGCTAAGGCGCGTTACGAGGGCGGCGTGGACGACTACCTGCGTTATCTTGACGCCCAGCGCAGCACCTTTAGCAACCAGACCACACTAATTCAAATCAGCACGGAACGGCAGATTGCGCTGGTTGACCTGTTCAGGTCTCTGGGCGGTGGCTGGGGCCAAACTGAACCGATGGCCGGGATCGGCGCTGAGTGA | Multi-drug resistance | Multi-drug RND efflux pumps | Drugs | 1 |
MEG_8260|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG | ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTACGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGCTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCCGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGGTTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA | MLS | MLS resistance ABC efflux pumps | Drugs | 1 |
MEG_8245|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF | ATGGATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGTTTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG | MLS | MLS resistance MFS efflux pumps | Drugs | 1 |
MEG_8418|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTGGATGCTAAAAGCGATATCTTGTTCAGTTTTAAGCTGGATGCTGTTAAGTGCATGCAGTCAGCAACCTCTTAAGGACCAAATGCAGCAGCCATTGATGATGCAACAACCACGGTTAGCTGAGTTGAATCATATGTTTCAAGCAGTGGGCAGTGCGGTAGTTTTTGTTACTTATGATGGGGAAAAATTGCAGCGTTTTGGCAATGATTTGCAAAGAGCTGAAACTGCCTATATACCTGCTTCAACTTTTAAAATGTTAAATGCTTTAATTGGTTTACAGCAGCGTAAAACCACGACCACTGAAGTATTTTTATGGGATGGAAAAGCACGCGCAATGAAAAGTTGGGAACGGGATATGACTTTGGCTGAGGCGATGCAAGTCTCAGCAGTTCCCATCTATCAAACCTTGGCTCGACGCATTGGTCTGCCGTTGATGCAAAAAGAGCTTCATCGAGTTGGTTATGGAAATGCTCAGATTGGTACACAGGTTGATCGCTTTTGGTTAGATGGACCCTTAAAAATTACACCGCAACAAGAAGCTGAATTTGCTTACAGACTTGCGACCCAGACCTTACCTTTTGATGCACATGTGCAACAAGAGGTGAAACAAATGCTTTATGTGGAGCGTCGTGGTGTTGCTAAGTTGTATGCTAAGTCAGGATGGGGAGCCGATGTAAAACCTCAGGTGGGTTGGTATGTGGGATGGGTGGAACAGCCCAATGGCAAAATTTTGGCCTTTGCTTTAAATATGCAGATACAGAATGAGCAGCAATTGGCAATGCGTAAACAGCTCACCCTAGATGCTTTAGATAAACTTAGTATCTTTCCTTATTTATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_7878|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC6-PRIME | ATGAGTACCAACCATGGCTCAGTCACACTGCGCCTCATGACCGAGCAGGACCTTCCCATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAGGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA | Aminoglycosides | Aminoglycoside N-acetyltransferases | Drugs | 1 |
MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML | GTGCCCAATCGTAAATCACCAACCTGGACCTATTCGGTGCCGGCAGCGTTGCTGCTGATGGCACCCTTCGACATCCTCGCCTCGCTGGCGATGGATATCTACCTTCCGGTCGTGCCGGCCATGCCCGGTATTCTCGGCACCACCCCGGCAATCATCCAGCTGAGCCTGAGCCTCTATATGATCGTTCTCGGCGTCGGGCAGATCGTCTTCGGACCCATTTCCGATCGCATCGGTCGGCGTCCCGTCCTCATCGGCGGGGCGCTCGCCTTTGCGGCCGCGTCATTGCTGATCGCCGCGACATCGTCGGCCCCGACCTTCCTTGCCCTGCGCCTCCTTCAGGCGATCGGCGCATCGGCAGCGCTTGTCGCCACCTTTGCGACGGTCCGCGACGTCTATGCGGAGCGGCCGGAGGGCGTGACCATCTACGGGCTCTTCAGCGCGATGCTCGCCTTCGTCCCGGCCCTCGGGCCGATCGCCGGCGCGCTTCTGGCCGATTACTTCGGCTGGCAGGCGATCTTCCTGACACTCGGTGTGCTGGCAATCGCCGCCACGGCAAACGCCCTGCCGCGATGGCGGGAAACGCGACCCGTCGGCGCCGAGGAGCAAAGGCGGGCTTTCGCCCCGATCCTTAAGGATGGAGCGTTCTGGACCTACACTCTCGGCTTCAGCGCCGCGATGGGCTCGTTCTTCGTGTTCTTCTCGACCGCACCACGCGTGCTGATCGACCGGGCGGGTTACTCCGAGCTCGGCTTCAGCCTGGTCTTTGCAACGGCAGCGGTGGTGATGATCGTCACCACCCGTTTCGCCAAACGCTTCGTCGCGCTTTGGGGCATCGCCGGCAGTTTTGCCCGCGGGATGGGGCTACTTCTCCTCGGCGCGATGCTGCTTGTCGTCGGGGAAAGCGTGTCCCCACCATCGTTCTGGACCTTCATTCTGCCGATGTGGGTCATTGCCGTCGGCATCGTCTTTACCGGCTCGGTCACCGCCAATGGAGCGCTGCAAGCCTTCGGCCACGTGGCGGGTACCGCAGTCGCGCTCTACTTCTGCATCCAAAGCCTGATCGTCGGGGTGCTCGGCACTGTGGCCGTGGTGCTGCTCGGCGGCGATACCGCCTTTCCATTAGCCGGCTATTCGTCGATCATGGCGATCGGCACGCTGATCGCTCTCGGTCGTTTGACACGGCAACGAGCGGCGGACGCCTGA | Phenicol | Phenicol resistance MFS efflux pumps | Drugs | 1 |
MEG_8247|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|MEXC1 | ATGAACAAATTCCGCGAATGGATCACTTTTTCCGTGATCTCCTGTTTGGTCGCCGTGACCCTGGTTGGCTGCGACAAGCCCGAAGAGCAACGGGAAGAGGCGCCAGCGCGTGAAGTCGATGTGCTCAGCGTGAAGACCGAGCCCTTCACAGTGTTCGCCGAGCTACCAGGGCGCATCGAGCCGGTGCGTGTCGCCGAGGTGCGCGCGCGGGTGGCGGGGATCGTGCTCAAGCGCACCTTCGAGGAAGGGGCCGACGTGAAGGCCGGTGACGTGCTGTTCCAGATCGACCCTGCGCCGTTCAAGGCGGCCCTGTCGCGGGCGCAAGGTGAACTGGCTCGCGCCGAGGCGCAGCTGTTCCAGGCTCAGGCGATGGTTCGCCGTTACGAACCACTGGTGAAGATCGACGCCGTCAGCCAGCAGGATTTCGACAACGCCATGGCCGCTCTGCAGAGCGCCCAGGCCGACAAGCGCTCGGCCCAGGCCAATGTCGAAACTGCCCGCCTGGACCTGGGTTATGCCGAGGTTCGCGCCCCCATCGCCGGGCGTATCGGTCGCGCCCAGGTCACCGAAGGGGCTCTGGTAGGCCAGGGCGAAGCCACGCTGCTGGCACGTATCCAGCAACTCGATCCGGTGTACGCCGACTTCACCCAGCCTGCTGCCGATGCCCTGCGCCTGCGCGCGGCAATCGCCGAGGGCAAGGTTGCCGGTGCGAGCGACCAGCCGCTGTCGCTGCGTGTCGACGGTACCGATATCGAGCGCAAGGGCACGCTGCTGTTCACCGATATCTCGGTGGATCGCAGCACCGGGCAGATCGCCCTGCGAGGCCAGTTCGACAACCCCGAGGGCGTGCTGCTGCCGGGTATGTACGTGCGTGTGCGCACGCCGCAGGGGCTCAACCAGAACGCCATCCTGGTGCCGCAACGTGCCGTGCAGCGTTCGGCTGACGGCCAGGCCAGCGTGATGCTGCTGGGCGAGGGCGATACCGTCGAGGTGCGCCAGGTCACTACTGGCGCCATGCAAGGCTCGCGCTGGCAGATCAGCGAGGGCCTGCAGGCCGGCGACAAGGTGATCACCAGCTCGCTGGCGGCTATCCGTCCGGGCGCCAAGGTCATCCCACGCGAGCAAGGCGCCGCCGAAAAAGCTCCACAGTCCCAAGCCCAGTAA | Multi-drug resistance | Multi-drug RND efflux pumps | Drugs | 1 |
MEG_8248|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|MEXD1 | ATGCCCCTGTTTTTCATCCGACGCCCCAATTTTGCCTGGGTAGTCGCCCTGTTCATCTCGCTAGGTGGCCTGCTGGTCATTCCGTTCCTGCCGGTGGCACAGTACCCCAACGTGGCGCCGCCGCAGATTACCGTGACCGCCACCTATCCCGGCGCCTCGGCGCAGGTGCTGACCGACTCGGTGACCAGCGTCATCGAGGAAGAACTCAACGGCGCCAAGAACCTGCTGTACTTCGAGTCCACCAGCAACGCCAACGGCATAGCCGAGATCACCGTCACCTTCCAGCCGGGGACCGACCCCGAACTGGCCCAGGTCGACGTGCAGAACCGTCTGAAGAAGGCCGAGGCGCGCATGCCGCAGGCCGTGCTGACCCTCGGCATCCAGACCGAGCAGGCCACCGCCGGCTTTCTGCTGATCTATTCGCTGCGCTACAAGGATGGCGACAAGAACGCCAACACCACGGCACTGGCGGACTACGCGGTACGTAACGTCAACAACGAGATTCGCCGTCTGCCCGGTGTCGGCAAGCTGCAGTTCTTCGACTCCGAAGCCGCCATGCGCGTGTGGATCGACCCGCAGAAACTGGTCGGTTACGGCCTGTCCATCGACGACGTCAACAACGCCATCCGCACCCAGAACGTGCAGGTGCCGGCCGGCGCCTTCGGCAGCACGCCGGGCTCCAGCGAGCAGGAGCTGACCGCGACGCTGACCGTCAAGGGCACCCTGGACAACCCCGAGGAATTCGCCGCCATCGTGCTGCGTGCCAACCAGGACGGCTCGCGCCTGACCCTGGGCGACGTGGCACGCATCGAGGTCGGCAGCCAGGACTACAACTTCGGCTCGCGCCAGGACGGCAAGCCCGCCGTTGCCGCCGCCGTGCAGCTGTCGCCCGGTGCCAACGCGATCCAGACCGCCGAGGCGGTCAAGCAGCGTCTGACCGAGCTGTCGGCCAACTTCCCGGACAACGTCGAGTTCTCCGTGCCGTACGACACCTCGCGCTTCGTCGACGTGGCCATCGACAAGGTCATCATGACCCTCATCGAGGCCATGGTGCTGGTGTTCCTGGTGATGTTCCTGTTCCTGCAGAACGTGCGCTACACCCTGATCCCGTCCATCGTCGTGCCGGTGTGTCTGCTTGGTACCCTGACCTTCATGTACCTGCTTGGCTTCTCGGTGAACATGATGACCATGTTCGGCATGGTGCTGGCCATCGGCATCTTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGATCATGGCCGAGGAAGGCCTGGCGCCGGTGCCGGCGACCATCAAGGCGATGGGGCAGGTGTCCGGGGCGATCATCGGTATCACCCTGGTTCTGTCGGCGGTGTTCCTGCCGCTGGCCTTCATGGCGGGTTCGGTGGGGGTGATCTACCAGCAGTTCTCGCTGTCGCTGGCGGTGTCGATTCTGTTCTCGGGCTTTCTCGCGCTGACCTTCACCCCGGCGCTGTGCGCCACGCTGCTCAAGCCGATTCCTGTAGGCCATCACGAGAAGACTGGCTTCTTCGGCTGGTTCAACCGCAAGTTCACCAGCCTGACCAGCCGCTACACGAAGCTCAACGACAAGCTGGTGCCGCGAGCCGGGAGGGTGATGTTCATCTACCTGGGCGTGGTGGTGCTGATGGGCTTTCTCTACATGCGCCTGCCGGAATCCTTCGTGCCGGTGGAAGACCAGGGTTACATGATCGTCGACATCCAGCTGCCGCCCGGCGCCACCCGTGAGCGTACCTCGGCCGCTGGTGGAGAGCTGGAGTCATTTCTGATGGCCCGCGAGGCCGTGCAGACGACCTTCCTGGTGCTTGGCTTCAGCTTCTCCGGCATGGGCGAGAACGCGGCCATTGCCTTCCCGCTGCTCAAGGACTGGTCCGAGCGAGATTCTTCGCAGTCGCCGGAAGCCGAGTCGGCTGCGGTCAACCAGCACTTCGCCAACCTCGATGACGGCGCGATCATGGCGGTGCCGCCACCGCCGGTCGAAGGCCTGGGCAACTCGGGTGGTTTCGCCCTGCGCCTGCAGGACCGCGCCGGCCTTGGCCGCGATGCCCTGTTGGCAGCGCGCGATGAAGTGCTGGGCAAGGTCAACGGCAATCCGAAGTTCCTCTACGCCATGATGGAAGGTCTGGCCGAGGCGCCGCAGCTGCGCCTGGTGATCGACCGTGAGCAGGCGCGCACGCTGGGAGTCAGCTTCGAAGCGATCAGCAGCGCGCTGTCCACTGCGTTCGGCTCGTCGGTGATCAACGACTTCGCCAACGCCGGCCGCCAGCAGCGCGTGGTGGTACAGGCCGAACAGGCCGAGCGCATGACACCGGAAAGCGTCCTGCGCCTGCATGTGCCCAACGACAGCGGCAGCCTGGTACCGCTGAGTGCTTTCGTCACCACGAGCTGGGAAGAAGGCCCGGTGCAGGTCGCGCGTTACAACGGTTACCCGTCGATCCGCATTGCCGGTGACGCCGCGCCCGGCGTGAGCACTGGCGAGGCGATGCTCGAACTGGAGCGCATCGCTGCCGAGCTGCCCGAAGGTATCGGTTACGAGTGGACCGGGCTGTCGTATCAGGAGCGGGTCGCCAGCGGGCAGGCGACGATGCTGTTCGCCCTGGCCATCACCGTGGTGTTCCTGCTGCTGGTGGCGCTCTACGAGAGCTGGGCGATCCCGCTGACGGTGATGCTGATCGTGCCGGTCGGCGCACTCGGCGCGGTACTGGCGGTGACTGCTATCGGCCTGCCCAACGACGTGTACTTCAAGGTCGGCCTGATCACCGTGATCGGCCTGGCGGCGAAGAACGCCATTCTCATCGTCGAGTTCGCCAAGGACCTGTGGGAAGACGGCTACTCGCTGCGCGATGCTGCTGTCGAAGCCGCGCGCCTGCGTTTCCGCCCGATCATCATGACCTCCATGGCGTTCATGCTCGGCGTGGTGCCGCTGGCCATCGCCACTGGCGCCGGCGCTGCGAGCCAGCGCGCACTGGGCACCGGGGTGCTGGGCGGGATGCTCAGCGCGACCATGCTCGGGGTGATCTTCGTGCCGATCTTCTTCGTCTGGGTGCTGTCGCTGCTGCGCACCAAACCTCAGCAAACCGACAACCATCCCCTGCATAAAGCGGAGTAA | Drug and biocide resistance | Drug and biocide RND efflux pumps | Multi-compound | 1 |
MEG_8420|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCGCCCTCTCTTCTTCAGCGCCCTTCTCCTACTCTTCTCCGGGCATGCCCAGGCCAGCGAATGGAACGACAGCCAGGCTGTGGACAAGCTCTTCGGCGCGGCCGGGGTGAAAGGCACCTTCGTCCTCTACGATGTGCAGCGGCAGCGCTATGTCGGCCATGACCGGGGACGCGCGGAAACCCGCTTCGTTCCCGCTTCCACCTACAAGGTGGCGAACAGCCTGATCGGCTTATCCACAGGGGCGGTTAAATCCGCCGACGAGGTTCTTCCCTATGGCGGCAAGCCCCAGCGGTTCAAGGCCTGGGAACACGACATGAGCCTGCGCGACGCGATCAAGGCATCGAACGTACCGGTCTACCAGGAGCTGGCGCGACGCATCGGCCTGGAACGGATGCGCGCCAATGTTTCCCGCCTGGGTTACGGCAATGCGGAAATCGGCCAGGTTGTGGATAACTTCTGGCTGGTGGGACCGCTGAAGATCAGCGCGATGGAGCAGACCCGCTTTCTGCTCCGACTGGCACAGGGAGAATTGCCATTCCCCGCCCCGGTGCAGTCCACCGTGCGCGCCATGACCCTGCTGGAAAGCGGCCCGGGCTGGGAGCTGCACGGCAAGACCGGCTGGTGCTTCGACTGCACGCCGGAACTCGGCTGGTGGGTAGGCTGGGTGAAGCGCAACGAGCGGCTCTATGGCTTCGCCTTGAACATCGACATGCCCGGCGGCGAGGCCGACATCGGCAAGCGCGTCGAACTGGGCAAGGCCAGTCTCACGGCCCTCGGGATACTGCCCTGA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8715|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET64 | TTGAATCCTTCCATGATTGCCATCCTGACGACCGTCGTGCTTGACGCGATCGGCGTCGGGCTCGTGATGCCGATCCTGCCCGGGCTGCTGCGCACCCTCGCCGGCGCGGGCGGCGCCGACACGCACTACGGCATGCTGCTCGCGCTGTACGCGCTGGCGCAGTTCCTGTGCGCCCCCGTCCTTGGCGCGCTGAGCGACCGCTTCGGCCGCCGGCCCGTGCTGCTCGCGTCGCTCGCGGGCGCCGCGCTCGACTACCTGCTGATGGCGTATGCGCCGACGCTCGCGTGGCTCTATGCCGGGCGGCTGATCGCGGGCATCACGGGCGCGAACGTCGCGGTCGCGACCGCGTACGTCACCGACGTGACCGCGGAACCCGATCGCGCGCGCCGTTTCGGTCAATTGGGCGCCGCGATGGGGATCGGCTTCATCGCCGGCCCGGTGCTCGGCGGCCTGCTCGGCGCGTGGCATCTGCGCGCGCCGTTCGCCGCCGCGGCGCTGCTCAATGCGCTCAATCTCGCACTCGTCTGGCGGAGCCTGCCGGAATCGCGGCCGCCGGCCGCGCGCGCCGGCCGCGCCACGGTGAGCCTCAACGCGTTCGCGAGCCTGCGGCGGCTGCGCGGCGGCCCGGCGCTCGTCCCGCTGATCGGCGTCTACGTGATCGTGGCGCTGGTGTCGCAGGCGCCCGCGACGCTGTGGATCCTGTACGGACAGGCGCATTTCGGCTGGTCGACGCCGGTCGCGGGCCTGTCGCTCGCCGGCTACGGCGCGTGCCACGCGCTCGCGCAGGCGTTCGCGATCGGGCCGCTGATCGCGCGGCTCGGTGAGCGTCGCGCGCTCGCGCTGGGCCTCGCCGGCGACGCGCTCGGCCTCGTGGTCATCGCGTTCGCCAACGCGGCCTGGGTGCCGTTCGCGCTATTGCCGCTGTTCGCGGCGGGCGGCATGACGCTGCCGGCGCTGCAGGCGATGCTCGCGCGCCAGGTCGACGATGCCCGGCAGGGCGAGCTGCAGGGCACGCTCGCGAGCGTCGCGAGCCTGATCGGCGTCGCCGGGCCGCTCGTCGTCACCGCGGCCTATGCGGCAACCCGCGACGCGTGGCCCGGGCTCGTCTGGGCCGCGGCCGCGTTGCTCTACCTGCTGGTGCCGCCGCTGCTGGCCCACGCGCGGCCGGCGCGAGAAAGTCCGGCCGCGTAA | Tetracyclines | Tetracycline resistance MFS efflux pumps | Drugs | 1 |
MEG_8653|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB | ATGACGCTCGCGCTGACCGCCGAAAAAATCGAAAGAAACCGCTTCACTGGGCTGAAAGTTGAAAACAGCACATTTCATCACTGTGATTTCTCCGGGGCTGACCTGACCGGCACGGAGTTTATCGGCTGCCAGTTTTATGACCGCGAAAATCAAAAGGGCTGTAATTTCAGCCGCGCCATTTTGAAAGATGCGATTTTCAAAAACTGTGATTTATCGATGGCGGATTTCAGGAACGCCAGCGCGCTGGGCATCGAAATTCGTGGCTGTCGCGCGCAAGGTGCAGATTTTCGCGGCACCAGTTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCCTACATCACTAACACCAATCTTAGCTACGCCAATTTTTCGAAAGCGGTGCTGGAGAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGCACTCAGGTTCTTGGCGCGACGTTCAGTGGGTCAGATCTCTCCGGCGGGGAGTTTTCCTCATTCGACTGGCGCGCAGCCAACGTGACGCATTGCGATCTGACCAACTCAGAATTGGGTGATTTAGACGTGCGGGGCGTTGATTTACAGGGCGTCAAACTGGATAGCTATCAGGTGTCATTGATAATGGAGCGACTTGGTGTCGCGATTATCGGCTAG | Fluoroquinolones | Quinolone resistance protein Qnr | Drugs | 1 |
MEG_8682|Drugs|betalactams|Class_C_betalactamases|RSC | ATGTACGGAAAAACCATAACCAGAGTGGGGGGCGTTGCCATTACCGCGCTGTTCCTCGGTGCCGGCAGCTGCGTCGCCGGGGATGATGTAGAAAAAAGGGTCAGGGCTGTCGTGGACGCAGCCATTCGGCCGGCTATGCAGGCGCATGCCATCCCTGGCATCGCGGTGGCGGTATCACTCAATGGGGAGCAGTATTACTTTAACTACGGCGTCGCCTCCAAAGAGAGTGGGCAGATGGTCACCGAGGATACGATTTTCGAGATCGGCTCGGTCAGTAAAACCTTCACGACGACCCTCGCATCCTACGCGCAGGAAAGTGGAGCGCTCTCCCTATCCGACCACGCAAGCCAATACCTGCCTTCGCTACGTGGCAGCAGTTTCGACAGCATCAGCCTGCTCGATCTTGCGACCTACACGCCCGGCGGTCTGCCGCTGCAGTTTCCGGACGCTGTGGACAGTCACGAAAAGATGATCGGTTATTACTACAACTGGAAACCGACCTATGCCGCCGGAACACACAGGCTCTACTCGAACCCGAGCATCGGCCTGCTCGGCTTTCTAACCGCTGAAAGCATGGGTGAGCCTTTCGAAGATCTACTGGAAAAGAAGCTGTTCCCGAAGCTCGGCCTAAGGCAGAGCTACATCAGGGTTCCACAAGAGCAGATGAGCCACTACGCGTACGGTTATAGCCGAGAGGACAAACCGATCAGGGTGGGCCCAGGCGTTCTGGATGCCGAGGCTTATGGCGTGAAATCCAGCTCGGCCGACATGATTCATTTCGTCGAGGCAAACATGCAGGCGGCTGATCTGGATGAGCCGCTGCAACATGCGATTGCCGCAACGCATAGGGGCTACTACAAGGTCGGCGACATGACTCAGGGGCTGGGATGGGAGTTTTACCCCTACCCGATAGAACTCGACCGTTTGCTTGCGGGCAACTCGGCCAAAATGATCCTTGAAGCGAATGAAATTACTCGACTCAACCCTCCGCTGATTCCGAAGGGCGACGTGCTCATTAACAAGACAGGCTCGACGAGCGGTTTTGGTGCATACGTGGCCTTTGTTCCAACCAAGGGTATCGGCATCGTGATGCTGGCGAACAAGAACTACCCCATCCCTGCAAGGGTGAAAGCCGCCCACCAAGTATTGACGGCCCTGGATGCTCGGACTGGATCTAATGCACACCATTGA | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8683|Drugs|betalactams|Class_D_betalactamases|RSD1 | ATGAAAAGTTACGTAGACAAGAAATGGATGATAATCTTTCTTATAGTGTGTGTATCCTGTACTTCAAAGGCGATAAAAAAAGAAGCATTTCCTGGTTTTAAACCTTTCTTTGATGAATACGGCGTGCAGGGTTGTTTTATTCTCTACGACCTGAAGAATGATAATTACGAGATATATAACTCTCAACGATGTGAGCAGGGCTTTCTGCCCGCTTCTTCGTTTAAGATCCTTAACGCCATGATTGGACTGGAAACCGGTGTTGTGACCAGTAAAGACATGGTTATCCCCTGGGATGGGGTTACAAGGGAGGTGGAAAGCTGGAACAGGGACCATACACTGGCCTCAGCCATCCAGAATTCGGTGGTTCCTTATTTCCAGGAAATGGCCCGCCGCATAGGTCCTGAAAGGATGAAAAAGTATGTCAATGAAGCCGATTACGGGCAAATGGATGTAACGGCCCAGACTATTGATCATTTCTGGCTAAGGGGGAATTCCCGCATCACTCCCTGGGAACAGATGAACTTTCTGCTGAACTTCTACCAGAATAAGCTGCCCATTTCTGAAACCAACATTGATATTGTCAAGCAACTGATCATCCTTGAAGAAAATGAACGTTGGATCTTTAGGGGCAAGACAGGCTGGGCCAAACAGGATGGTCAGAACATTGGCTGGCTGATCGGTTATTATGAAAATGATAAAAATACCTGGCTTTATGTCTGCAACGTTGAGGCTTCAGATAACAATATCGAGAACTTCAAAGCCAGCAGACGCGGCATTACTGAAAAAGTGTTTAAATCAATGGGTTTGATGGAGTAG | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8102|Drugs|Aminoglycosides|Gentamicin-resistant_ATP-binding_protein|GAR | ATGATTATTCTGCTTAATGGACCGCTCGGAATCGGTAAATCCACGCTATCTGAGGCATTGACGGAACGGGTTGATTGGTGCGCCATGCTTGACGGCGACCACCTCATCGAACTCAATCCACCTCCTGCCAATGAGCAGGAAACGCTTCTTTCTGTGAGCACACTGCTCATTGCTCACTATCAGAGCGTCGGCTACCGCAACTTCGTTCTCAATCACCTGTGGACCGTTCCCGCCGACCTCAGTCAGTTTCGCGCCAAGCTTTCGGAGCTTGACTCAGACGTTCATTGCTTCCGTTTGACATTGCCGGTTGAGGAGAACCTCCGACGTATTGAGCGTAGAGCAAGTGCAACCGGACTTGACCGATCGTACGAGTTGGAGGTGTTTGCCGAGGAGCACACAGTTTTCTCTGGATGTTACGGACACGAACTTGGCGTTCCACTAGATGCATCGAGTTCGCCAGGCGAGCTTGCGAGCCAAGTTCTGGCGTTGCTTGGACTTCATTAG | Aminoglycosides | Gentamicin-resistant ATP-binding protein | Drugs | 1 |
MEG_8431|Drugs|betalactams|Class_D_betalactamases|OXA | ATGAAAATTCTGATTTTACTGCTTTTAGTTAGTTGCTTGGGCCTGACGGCGTGTAGCCTGCCCGTTTCATCTTCCCCATCTCAAAGCACTTCAACTCAATCTACCCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCAGGTGTTTTAGTGATTCAGCGTGATCAACAGATACAGGTCTATGGCAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTTCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGGAACAGGAAGTGAGACGTATTCAATTCGGCAATCAACATATTGGGCAGCAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTTTTACAGGAACAGCAAGCTTATCGCCTATATGCCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATGGATCCGGCGATCCGCCTTGAGATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8007|Drugs|betalactams|Class_A_betalactamases|BLAPAM | ATGCGTTTGCTCGCCAGCCTCGCGCTGCCCCTGTTCGCCGCCAACCTGGCGGTCGCCGCCCCCGCCCAGCTGCCCCAGCTGGAGGCCTACAAGGGCCTCGACGCCTGGCTGGTGCCGGTGGAGCCCCTGCGCATCAGCGACCACGTGTGGCAGATCGGCACCGCCAGCATCAGCGCCCTGCTGGTGAAGACCGACGCCGGCGCGGTGCTCATTGACGGCGGCATGCCCCAGGTGGCCGACCACCTGCTGGCCAACATGAAGAAGCTCGGCGTGGCCCCGCAGGATGTGCGCCTGATCCTCCACAGCCACGCCCACATCGACCACGTCGGCCCGCTGGCGGCAATCAAGCGCGCCACCGGCGCCATGCTGGTGAGCAACGCCGAATCCGCCGTGCTGCTGCAGCGCGGCGGCGCCAACGACATCCACTTCGGCAGCGGCATGCTCTTCGAACCGATCCAGACCGACCGCCTGGTGCAGGACGGCGAGGCCGTGACCCTGGGCGACACCACCTTCACCGTGCACTTCACCCCGGGGCACACGCCCGGCAGCATGAGCTGGACCTGGGCCGACACCCGGGACGGCAAGCCCCTGCGCATCGCCTACAGCGACAGCCTCAGCGCGCCGGGCTACCAGCTGCGCCACAACGCCCGCTACCCGCACCTCGTGGAAGCCTTCCGCGCAAGCTTCGCCGCCGTCCGCGCCCTGCCCTGCGACCTGCTGCTCACGCCCCACGCCGAAGGCAGCGGCTGGGACTACGCCAACGCCGCCAGGCCGCACCCGCAGCCGGTCAGCTGCAAGGCCTACGCGGACAAGGCCGAGGCGAATCTCGACAAGATGCTCGCCGAGCAGGCGAACAAGCGCTGA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8069|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA | TTGAAAATTTCATTAATCGCAGCGCAGTCAGAAAATGGCGTTATTGGTAATGGTCCAGAAATTCCATGGTCGGCGAAAGGTGAGCAGTTACTATTTAAAGCGCTAACATATAATCAGTGGCTTCTTGTTGGAAGAAAAACGTTTGAGTCTATGGGTATTCTTCCAAATAGAAAGTATGCTGTTATTTCAAAAAATGGAATTTCACCTCATCCTGAAAATGTACTAGTATTTTCGTCCATTGAAAATGCATTAAATGAATTGCCCAATATAACAGAGCATTTATATATTTCTGGCGGTGGTCAAATATATAATAGCCTTATTGAAAAGGCAGATACTATCCACTTATCTATTGTTCACACGGTGGTAGAAGGCAATGTAATATTTCCAAAAATACCTTCTAATTTCAATTTGGTATTTGAGCAATTCTATTCGTCAAATATTAATTATACTTATCAAATTTGGCAAAAAGGTTAA | Trimethoprim | Dihydrofolate reductase | Drugs | 1 |
MEG_8034|Drugs|betalactams|Class_C_betalactamases|CMY | ATGATGAAAAAATCAATATGCTGCGCGTTGCTGCTGACAGCCTCTTTCTCAACGTTTGCCGCGTCAAAAACAGAACAACACATTGCCGATATCGTCAATCGCACCATCACACCGCTGATGCAAGAACAGGCTATTCCGGGTATGGCCGTGGCGATTATCTACCAGGGGAAACCGTATTACTTTACCTGGGGTAAAGCCGATATCGCCAATAACCGTCCCGTTACTCAGCAAACACTGTTTGAACTTGGCTCGGTCAGTAAGACGTTCAACGGCGTGTTGGGTGGCGATGCTATCGCCCGCGGCGAAATCAAGCTCAGCGATCCGGTCACGCAATACTGGCCAGAATTGACGGGCAAACAATGGCGGGGTATCAGCATGCTGCACTTAGCCACCTATACGGCGGGTGGTCTGCCGCTTCAGATCCCCGACGACGTTACGGATAAAGCCGCATTACTGCGCTTTTATCAAAACTGGCAGCCGCAATGGGCTCCAGGTGCTAAACGTCTCTATGCTAACTCCAGTATTGGCCTGTTTGGCGCACTAGCGGTGAAACCTTCAGGGATGAGCTATGAAGAGGCGCTAACCAGACGCGTCCTGCAGCCTTTAAAACTGGCGCATACCTGGATTACGGTTCCACAGAGCGAACAAAAAGATTATGCCTGGGGCTATCGCGAAGGAAAGCCAGTGCATGTTTCCCCCGGACAACTTGATGCCGAAGCCTATGGCGTGAAATCCAGCGTCGTCGATATGACTCGTTGGGTTCAGGCCAACATGGACGCCAGCCAGGTTAAGGAGAAAACGCTCCAGCAGGGCATTGAGCTTGCGCAATCACGTTACTGGCGTATTGGCGATATGTATCAGGGACTGGGCTGGGAGATGCTTAACTGGCCGGTGAAAGCCGACTCGATAATCAGCGGTAGCGACAGCAAAGTAGCGCTGGCAGCACTTCCCGCCGTTGAGGTAAATCCGCCAGCCCCGGCCGTGAAAGCCTCATGGGTGCATAAAACAGGGTCTACTGGCGGATTTGGCAGCTACGTTGCCTTCGTGCCAGAAAAAAAACTTGGCATCGTGATGCTGGCAAACAAAAGCTACCCTAACCCGGCTCGCGTAGAGGCCGCCTGGCGCATCCTGGAAAAGTTGCAATAA | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8655|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB | ATGACGTTGTCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTAAACTGTGATTTTTCGGGCGTCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAACCAGAAAGGGTGCAATTTCAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCAATGGCGGATTTTCGCAACGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAGGGTGCAGATTTTCGCAGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAACCGATGGATGGGAACTCAGGTGCTGGGTGCGACCTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGACTGCAAATTTTACGCATTGTGATTTGACCAATTCCGAACTGGGTAATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTACCAGGCCGCGTTGCTGATGGAGCGGCTTGGTATCGCTGTGATTGGTTAA | Fluoroquinolones | Quinolone resistance protein Qnr | Drugs | 1 |
MEG_8239|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR | ATGCCTTCCCTTATAAAAATAAAAATTGTTCCGCTTATGTTTTTTTTGGCACTGTATTTTGCATTTATGCTGAACTGGCGTGGAGTTCTCCATTTTTACGAAATCCTTTACAAATTAGAAGATTTTAAGTTTGGTTTCGCCATTTCATTACCAATATTGCTTGTTGCAGCGCTTAACTTTGTATTTGTTCCATTTTCGATACGGTATTTAATAAAGCCTTTTTTTGCACTTCTTATCGCACTTAGTGCAATCGTTAGTTACACAATGATGAAGTATAGAGTCTTGTTTGATCAAAACATGATTCAGAATATTTTTGAAACCAATCAAAATGAGGCGTTAGCATATTTAAGCTTACCAATTATAGGATGGGTTACTATTGCTGGCTTTATCCCTGCCATTTTACTTTTCTTTGTTGAAATTGAATATGAGGAAAAATGGTTCAAAGGGATTCTAACTCGTGCCCTATCGATGTTTGCATCACTTATAGTGATTGCGGTTATTGCAGCACTATACTATCAAGATTATGTGTCAGTGGGGCGCAACAATTCAAACCTCCAGCGTGAAATTGTTCCAGCCAATTTCGTTAATAGTACCGTTAAATACGTTTACAATCGTTATCTTGCTGAACCAATCCCATTTACAACTTTAGGTGATGATGCAAAACGGGATACTAATCAAAGTAAGCCCACGTTGATGTTTCTGGTCGTTGGTGAAACCGCTCGCGGTAAAAATTTCTCGATGAATGGCTATGAGAAAGACACCAATCCATTTACCAGTAAATCTGGTGGCGTGATCTCCTTTAATGATGTTCGTTCGTGTGGGACTGCAACCGCTGTATCTGTCCCCTGCATGTTCTCCAATATGGGGAGAAAGGAGTTTGATGATAATCTCGCTCGTAATAGCGAGGGTTTGTTAGATGTGTTGCAGAAAACGGGGGTCTCCATTTTTTGGAAGGAGAACGATGGCGGCTGCAAAGGCGTCTGCGACCGAGTTCCTAACATCGAGATCAAACCGAAGGATTACCCAAAGTTCTGCGATAAAAACACATGCTATGACGAGGTTGTCCTTCAAGACCTCGATAGTGAAATTGCTCAAATGAAAGGGGATAAGCTGGTTGGCTTCCACCTGATAGGTAGCCATGGCCCAACCTACTACAAACGCTACCCTGATGCTCATCGTCAGTTCACCCCTGATTGTCCACGCAGTGATATCGAAAACTGCACGGATGAAGAGCTCACCAACACCTATGACAACACCATCCGCTACACCGATTTCGTGATTGCAGAGATGATTGCCAAGTTGAAAACCTACGAAGATAAGTACAACACCGCATTGCTCTACGTCTCCGATCACGGTGAATCACTGGGAGCTATGGGGCTTTACCTGCACGGTACACCGTACAAGTTTGCACCGGATGATCAGACCCGCGTACCTATGCAGGTGTGGATGTCACCTGGTTTCATCAAAGAAAAAGGCATGAATATGGAATGTTTGCAGAAAAATGCCGCAGCCAATCGCTATTCTCATGACAACATATTTTCTTCTGTCCTGGGAATATGGGATGTGAAGACAGCTATCTACGAACAAGAATTAGATATCTTTAAGCAATGTCGGAATAATTGA | Lipopeptides | Colistin phosphoethanolamine transferase | Drugs | 1 |
MEG_7904|Drugs|betalactams|Class_C_betalactamases|ACT | ATGAAGACAAAATCCCTTTGCAGTGCCCTGCTGCTCAGCACCTCCTGCTCTGTTCTCGCCGCGCCGATGTCAGAGAAACAGCTGTCTGACGTGGTGGAACGTACCGTTACCCCCCTGATGAAAGCGCAAGCCATTCCGGGCATGGCGGTAGCGGTGATTTATCAGGGTCAGCCGCACTACTTTACCTTCGGAAAGGCCGATGTTGCGGCGAACAAACCTGTCACCCCGCAAACCCTGTTTGAGCTGGGCTCTATAAGTAAAACCTTCACTGGCGTATTAGGTGGCGATGCGATTGCGCGCGGAGAAATATCGCTGGGCGACCCCGTGGCAAAGTACTGGCCCGAGCTAACAGGCAAGCAGTGGCAGGGTATTCGCATGTTGGATCTGGCGACCTACACCGCGGGTGGCCTGCCGCTACAGGTGCCGGATGAGGTCACGGATAACGCCTCCCTGCTGCGCTTCTATCAACACTGGCAACCGCAGTGGAAACCAGGCACAACGCGTCTTTATGCGAACGCCAGCATCGGGCTTTTTGGCGCCCTCGCGGTTAAACCCTCCGGTATGAGCTTTGAACAGGCCATGACGAAGCGGGTCTTCAAGCCACTCAAACTGGACCATACATGGATTAACGTTCCGAAAGAAGAAGAGGCGTATTACGCCTGGGGATACCGTGATGGTAAAGCGGTCCACGTTTCACCGGGAATGTTGGATGCCGAAGCGTATGGTGTCAAAACCAACGTCCAGGATATGGCGAGCTGGGTGAAGGCCAACATGAACCCTGCCGCTCTTCCGGATTCAACGCTGAAACAGGGTATTGCCCTGGCACAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCGGTAGAATCCAAAACCGTCGTGGAGGGCAGCGATAACAAGGTGGCTCTTGCACCGTTACCGGTGGCAGAAGTGAACCCTCCAGCTCCGCCAGTAAAAGCATCATGGGTACATAAAACAGGCTCGACGGGTGGATTCGGCAGCTATGTCGCATTTATTCCTGAGAAGGAACTCGGCATTGTTATGCTGGCGAACAAGAGCTACCCGAACCCGGCGCGCGTGGAAGCGGCATACCGTATTCTGAGCGCTCTGCAGTAA | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8713|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET62 | ATGCAGACGGAAGCACGGATCAATAAATCTCTGGCCATTGTGCTCAGTGTCATTGTGCTGGATGCAATGGGGCTCGGGCTTGTGATGCCGGTTCTGCCGGAGTTGTTGCGCGGACTGGTGCCAGGCGGACAGGTAACAGGGCATTATGGTATGTTGCTGGCTGTCTATGCGCTGATGCAGGTGTTCTTTGCGCCGCTGCTAGGGCGATTGTCAGATCGCTATGGCCGCCGTCCGGTGCTGATTATGTCGCTTGCCGGTGCAGCAATTGACTATGCCGTCATGGCAGCAGCACCGGTGCTCTGGGTGATTTATATCGGCCGCATGATTGCCGGTATTACCGGAGCGACAGGTGCGGTTGCGGCATCGGCGATTGCCGATACGATGCCGTCAAACCAGCGGGCGCGCTGGTTCGGTTATATGGGCGCCTGTTACGGTGCCGGAATGATTGCGGGGCCTGCGATCGGCGGGCTGGCAGGCAGCCTGTCTGTGCACGCCCCCTTTATCGCGGCTGCTGTACTGAACGGAACCGGTTTTCTGCTGGCTTATCTTTTTCTCAAAGAGACACGTCCGGCAGGTTCGCAGCCGGCAGTTTCAGAAACATTCAGTTTGCGTGAGTTTCTGTTGCCGGTCAGCTTTCTCAAAGGGATGACCGCACTTGCGCTGGTGTTTTTCATTATCCAGCTGGTGGGGCAGCTTCCTGCAACATTGTGGGTGATCTATACGGAAGATCGTTTCGCGTGGGACACAACCATGGTCGGCTTTTCACTGGCGGCTTTCGGTGCCGTGCATACCGTGTTTCAGGCTTTTGTGACCGGCCCGCTCTCAGCCCGTTTTGGTGAGCGCCGCACATTGATCATCGGCATGGCTGCCGATGCCTGCGGTTTTCTGGCGCTGGCCATGATCACGCAAAGCTGGATGATACTGCCGGTACTATTGCTGCTGGCAACCGGCGGTGTCGGCATGCCCGCATTGCAGGCAATGTTGTCTGGGGCTGCCGGAGAGGATGAGCAGGGGAGTTTGCAGGGCACACTGACCAGCCTGACGAACCTGAGTTCGATTATCGGGCCCCTTGGTTTCTCGGCTTTCTACGCAATAACCGCAGTTGCATGGAATGGCTGGGTGTGGATTGGCGGTGCTGCGCTTTATTGCATCAGCTTCGCGATCCTGCGCCGGTCTTCATAA | Tetracyclines | Tetracycline resistance MFS efflux pumps | Drugs | 1 |
MEG_8066|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA | TTGAAAGTATCATTGATGGCTGCAAGAGCGAAAAATGGCGTAATCGGTTGCGGTCCTAACATTCCTTGGTCTGCCAAAGGGGAACAGCTTCTTTTCAAAGCACTGACCTATAACCAATGGCTTTTGGTAGGGCGCAAAACATTTGAGTCTATGGGGCCGCTGCCCAATAGGAAATACGCGGTTGTTACCCGCTCAAACTGGACAGCGGCTAATGAAAACGTAGTGGTTTTCCCGTCGATTGACGAAGCGATGGGTAGATTAGGCGAGATCACTGACCATGTCATCGTCGCCGGTGGTGGAGAAATCTACCATGAAACGATACCCATGGCCTCTACTCTGCATGTGTCGACAATCGACGTTGAGCCAGAGGGAGACGTTTTCTTTCCGAACATTCCTGGGAAGTTTGATGTCGTTTTTGAGCAACAATTTACATCAAACATTAACTATTGCTATCAAATCTGGCAAAAGGGTTAA | Trimethoprim | Dihydrofolate reductase | Drugs | 1 |
MEG_8068|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA | TTGTTTTTGAGTGTGGGTATGGCATTTCAGGATTTAGAAGTCGTTCATGTCGTTGCAATGGATCAGCAGCGCTGTATTGGTAAGGACAATGACCTGCCTTGGCATATCTCAGCAGATCTAAAACATTTTAAGGAAATCACCCAGGGCGGTGTAATTGTAATGGGACGTAAGACCCTTGAATCCATGGGACGTGCCTTGCCTAAACGTGTCAACTGGGTCATTACCCGTGATACAGACTGGTCTTTTGAAGGTACTAAAGTCGCACACACGATTGAAGATGCCTTGAACCAAGCTGTTGCAGATGTAAAAGCGTCAGAAAAACCGGAGTCTATTTATATTATTGGGGGTGGTGAAATCTTCAAACAGACAATGAGTATTGCTGACCGTCTGGAACTGACCCATGTCGAACTGGATGTACAAGGTCATGCCTTCTACCCGGAAATTCCTGCTGAATTCAAAAAAGTTTTTTCCGAACAACATATCGACGACAAAACTGGGATTGCTTTTGAGTTTGCAACTTATAGAAAATGA | Trimethoprim | Dihydrofolate reductase | Drugs | 1 |
MEG_8719|Drugs|Tetracyclines|Tetracycline_inactivation_enzymes|TETX | ATGAGTTTATTAAACAATAAAAAAGTTGCAATTATCGGTGGCGGACCAGTTGGACTAACAATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA | Tetracyclines | Tetracycline inactivation enzymes | Drugs | 1 |
MEG_8658|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRVC | ATGGAAAAATCAAAGCAATTATATAATCAAGTAAACTTCTCACATCAGAATTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGGTCAAACCTTCGAGATTCACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTCCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAACTTATTGAAAAGTGTGATCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCGGCAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAACTTAATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATAATTGTTCCTGACTAA | Fluoroquinolones | Quinolone resistance protein Qnr | Drugs | 1 |
MEG_8240|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR | ATGCCCGTACTTTTCAGGATGAGGGTAATCCCCCTGGTTTTACTTCTGGCACTCGTTTTTGCATTCTTACTTAACTGGCCGGTGTTGCTGCATTTCTACGATATCCTGAGCCGTCTTGAACATGTGAGGGCGGGGTTCGTCATCTCCATTCCGTTTGTGCTGGTTGCAGCGCTTAACTTTGTGTTTATGCCCTTCTCGGTTCGCTACCTGCTTAAACCCTTCTTTGCCCTGTTGCTGGTCACCGGTTCGGTGGTGAGTTACGCCACACTGAAATATAAAGTGATGTTTGATCAGTCCATGATCGAAAATATACTGGAAACAAACCCACAGGAAGCGCATTCCTACCTGAATGGCTCACTGGTGCTGTGGCTGGTCTTTATGGGCATTCTTCCGGCTATCCTGTTGTTTTTGATTAAAATTGAATATACAGACAAATGGTACAAAGGGGTTGCCCACCGGCTGCTTTCCATGCTCGCTTCGCTGATCCTGATTGCAGGTGTTGCCGCTCTGTATTACCAGGATTATGCTTCTGTCGGGCGCAATAACCCGACGCTGAACAAAGAAATTATCCCGGCAAACTATGCGTACAGCACTTTCCATTACGTGAAGGATACCTATTTTACGACGAAAATGCCTTTCCGGACGCTGGGGGATGATGCAAGGCGCGTTACCCGGAATGGTAAACCCACGCTGATGTTCCTGGTAATTGGCGAAACGGCACGGAGCCAGAATTTCTCCATGAACGGCTACCCGCGTGACACAAATGCCTTTACCAGCAAAATCGATGGCGTTATTTCGTTCAGGAATATGCGTTCCTGCGGCACGGCGACCGCAGTCTCGGTGCCCTGTATGTTCTCGGATATGAACCGGACGGATTACGATGGTAAAAAGGCTGCCGGCAGTGAAAATGTCCTCGACATTGTGCAGAAAACGGGGGTTTCGCTGTTGTGGAAAGAAAACGATGGCGGGTGTAAAGGCGTATGCAGCCGTATCCCGACTGTCGAAATTAATCCCGGTATCAGTAAAAAACTGTGTGACGGTAAAACCTGCTATGACGATGTTATGCTGGAAAACCTGGATACCGAAATCGGCAAAATGGCCGGAGACAAGCTGATCGCCTTCCATATGATTGGCAGCCATGGACCGACCTATTACCAGCGTTATCCGGCAGAGCATCGTCACTTCATGCCGGAATGTGCGCGCAGCGATATCGAAAACTGCACGCAGGAACAGCTGGTTAATACCTACGACAATACCATTCGCCACACCGACTATGTGTTAGCGCAGATGATTGAAAAGCTTAAGCAATACAGCGAACAGTACAACACCGTACTGCTGTATGTGTCCGATCACGGCGAATCTCTGGGAGAGAGCGGACTGTATCTGCACGGTACCCCCTACAAACTGGCACCGGATCAGCAGACGCACATCCCGATGCAGCTCTGGATGTCGCCAGACTTCATTGCTGCTAAAAATATTAACGCCGCGTGTCTGCAGCATAATGCCGTTAACAGGACATATTCCCACGATAACCTTTTCGCGTCCGTACTGGGGCTCTGGGACATCACCACCGGGGCCTATCTTCCGGAAAGCGACCTGTTCCGCGAATGTCGTGGATAG | Lipopeptides | Colistin phosphoethanolamine transferase | Drugs | 1 |
MEG_8638|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT | ATGAAAGGTAAAAATATGAATTTAGCCTTTGGGTTGGAAGAAATTTATGAGGATGCTGAGTTTCAAATCGGAGATTTGGATAAGGTCGGTATTGTCGGCGTGAACGGAGCCGGAAAGACCACCTTGTTCCGCCTGCTGTTGGGAGAACTTGAACTTGATAATGGTTCACTGACCAGTGGAAATGCCCGTATTGGTTATCTCCCACAGGAAATTGTCTTGGAAGATGAGGATATTACCGTTTGGGATTTCCTTTTTGAGGGACGTCCGATTAAAAAGTATGAGCAGGAATTGGAAGAAATCTATAAAAAGCTTGAAACCGCAGTCAATGCAGAGCAGGAAGCACTGCTTGCCCGAATGGGAACATTGCAAGAACGCTTGGAGTATTTCGACTTCTATGAGGCAGAAACAATTCTGTTGGAGTTTGCAGATAAAATGAGCATTGATGCAGAATTATATCATCGTCCGATGAGAGAGCTTTCAGGCGGACAAAAATCCAAAATGGCATTTGCCAGACTACTATATTCAAAACCGGAAATTCTATTGTTGGATGAGCCTACCAACCATTTAGATGTCAGCACAAAGGATTTTGTTATAAAATACTTAAAGAATTATAGGGGTTCGGTACTGATTATCAGCCATGATATTGATTTTCTAAATCGGATTATCAACAAAATTATGTACATCAACAAAGCTACCCATAAAATATCTGTTTATGATGGAGACTACTACATCTACAAGAAAAAGTATGCAGAGGAACAGCGGATTCGTGAAATGGCGATTGTACAGCAGGAAAAAGAAATAAAGGAGCTTTCCGATTTTGTACAAAAAGCAAAACAAGCCAGTCAGACCAATCATCACCTCAAACGAATGGGTCAAGAGCGAGCCTTGCGGCTTGATAAAAAGCGTGGAGAGCTGCAAAAGAGAAATCGACTGTACAAGCGTGTGAAGATGGATATTCGCCCCAAGCGTGAAGGGGCACAAGTTCCCTTAGAGGTGGAAAATATCACCTTCCACTATTCGGGGTATCCCACCCTTTATCAGAACCTTTCCTTTCAGATTAACGGAAGAGAACGATTTCTTGTGGTGGGTGAAAACGGTGTCGGTAAATCCACCTTATTGAAATTGATGATGGGTATTCTCAGTCCAGATGAAGGATGCATTCGCTTTAACCAGAAAACTGATATTGCATATTATGCACAGGAACTCGAACAGCTTGATGAAAACAAAACGGTCATTGACAATGTGGAGTCTGAAGGATATACACCGTGGCAAATCAGAGCCGTACTGAGCAACTTCCTGTTTTATGATGACGATGTAAACAAGAAAGTATCTGTGCTGTCCCCTGGAGAAAAAGCAAGGGTTGCCCTTTGCAAAATCCTATTACAGAAAGCCAATCTTTTGATACTGGACGAGCCGACCAACCACCTTGACCCAGAAACGCAGAAAATCATTGGCGGCAACTTCAATTTGTTTGAGGGAACCATTATTGCCGTTAGCCATAACCCATCCTTTGTGGAACAAATCGGAATTAGCCGTATGCTTATTTTGCCCAGCGGTCGAATTGAACCCTATTCCCGTGAGCTGCTTGAGTATTATTATGAAATCAACACTCCCGAAGAAGAACAGAAATACTAA | Multi-drug resistance | Multi-drug ABC efflux pumps | Drugs | 1 |
MEG_8207|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGGATGACAAGGATGACAAGTACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8421|Drugs|betalactams|Class_D_betalactamases|OXA | ATGACAATCCGAATCTTTGCAATATTTTTCTCCACTCTTATTTTTGCCACTTTCGCGCATGCACAAGAAGGCACGCTAGAACGTTCTGACTGGAAGAAGTTCTTCGACGATTACCAAGCCAAAGGCACGATAGTTGTGGCAGACGAACGTCAAGCAGATCGCATCCTATCGGTTTTTGATCAAGCACGGGCGACAAAACGTTACTCGCCTGCATCAACATTCAAGATTCCACACACACTTTTTGCACTTGATGTAGGTGCTGTTCGTGATGAGTTCCAGGTTTTCCGATGGGACGGTATTAAACGAAGCTTTGCAGGACACAATCAAGACCAAAACTTGCGATCAGCTATGCGAAACTCTACGCTCTGGGTTTATGAGCTATTTGCAAGAGAGATCGGTGAGGAAAAAGCCAAACGCTATTTAAAGCAAATAGGTTATGGCAACGCCGACCCTTCGACAAGCAAAGGCGATTATTGGATAGATGGCACTCTAGAAATTTCTGCGTACGAACAGATTTCGTTTCTCAGAAAACTCTATCGAAATGAATTGCCATTTCGGGTAGAGCATCAGCGCTTGGTCAAAGATCTCATGATTACGGAAGCCGGGCGCAACTGGATTCTGCGCGCAAAGACTGGCTGGGAAGGTAGGTTTGGCTGGTGGGTGGGATGGGTTGAGTGGCCTACCGGCGCCGTATTCTTCGCATTGAATATCGATACGCCAAACAGAATGGATGATCTTTTCAAAAGAGAGGCAATCGTGCGGGCAATCCTCCACTCTATCGACGCGTTGCCGCCCAACTAGT | betalactams | Class D betalactamases | Drugs | 1 |
MEG_7972|Drugs|betalactams|Class_B_betalactamases|AIM | ATGACGCTCCGCTCCACCCTGCTTTCCGCTCTGGTCGCGCTCGCGCTTCCCTCCGCCGCGCTCGCTTCCGACGCGACCACGGCCAAAGCCTGCGCCGACGATGCCGGCTGGAACGATCCCGCCACGCCGCTGAAGGTCTACGGCAACACCTGGTACGTCGGCACGTGCGGCATCAGCGCCTTGCTGGTGACCTCCGATGAAGGCCACATCCTGGTCGACGCCGCCACGCCGCAGGCCGGCCCGCAGATCCTCGCCAATATCCGCGCCCTCGGCTTCAAGCCGGAGGATGTGCGTGCCATCGTGTTCTCGCACGAGCACTTCGACCATGCCGGCAGCCTGGCCGAGTTGCAGCAGGCCACGGGCGCGCCTGTGTATGCGCGTGCGCCTGCCGTTGCCACGCTCAAGCGCGGCGCCAGCGATCGCAGCGATCCGCAGCATGAGGTACTCGATCCGTTCGCGCCGGTCCAGCAGGTGGTCGTACTCGACGACGACGGCGTGGTGCGTGTCGGTCCGCTCGCCCTGCAGGTCGTTTCCACGCCGGGACACACGCCCGGCGGCACCAGCTGGACCTGGCGCTCGTGCGAGGGCGACGACTGCCGGCAGATGGTCTACGCCGACAGCCTGACCGCGATCTCCGACGACGTGTACCGCTACAGCGACGATGCGGCGCACCCTGGTTACGTGGCGGCATTCCGCGAGACGCTGGCGCGGGTCGCGGCACTCGAGTGCGACATCCTGGTGACGCCACATCCGTCGGCCAGCCAACTCTGGTCCCGCATCGGTCCTCGCGCCGACCGCCCGCTGGTCGACACCAGCGCCTGCCGCACCTATGCACAGACCGCGACGCAGCGGCTGGACAAGCGGCTCGCGGACGAAGCGTCGAAGCCCCCCGTGCCTGCGCCTTGA | betalactams | Class B betalactamases | Drugs | 1 |
MEG_8416|Drugs|betalactams|Class_D_betalactamases|OXA | ATGAATAAAGGTTTGCACAGAAAGCGCCTGAGTAAGCGTTTGCTGCTGCCCATGTTGTTGTGTTTATTGGCTCAGCAAACGCAGGCAGTGGCAGCGGCGCAGACCAAGGTCAGTGAAGTCGGCTCTGAGGTCACGGTCGAGGGTTGGCAAGAGGTACGCCGCTGGGACAAGTTGTTTGAATCTGCAGGTGTTAAAGGCTGTTTGCTGCTTTTGGATCAAAAGCGTTCTTTGGGGCTATCTAACAATCTAAGTCGCGCCGCCGAAGGCTTTATTCCTGCTTCTACCTTCAAGATCCCCTCTAGCCTGATTGCGTTGCAAACCGGGGCGGTGCGCGATGAAACCAGTCGTTTTAGCTGGGACGGAAAAGTTCGGGAAATTGCTGCCTGGAACCGGGATCAGAGTTTTCGCACCGCAATGAAGTACTCCGTGGTGCCTGTGTATCAGCAGCTGGCCAGGGAGATAGGCCCCAAAGTGATGGCAGCTATGGTGCGGCAACTGGAATATGGTAATCAGAATATCGGTGGCCAAGCGGACAGCTTCTGGCTCGACGGTCAACTTAGGATAACGGCGTTCCAACAAGTGGATTTTCTGCAGCAACTGCATGACAACAAGTTGCCTGTGTCTGAGCGCAGCCAGCGAATTGTCAAACAGATGATGCTGACCGAAGCGAGTACTGACTATATCATTCGCGCCAAGACAGGCTATGGTGTACAGCAAACGCCGGCCATAGGTTGGTGGGTCGGTTGGTTGGAGTTGGACGACAATACTGTCTATTTCGCCATTAATCTGGAGCTGACCTCCGCAAGCCAGTTACCGTTGCGCCAACAACTGGTGAAACAGGTGCTCAAGCAGGAACTGCTACTGCCTTGA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8681|Drugs|betalactams|Class_A_betalactamases|RSA | ATGCAACTAGCTAGGTCGACGATCCTCACTGTTTTGCTCTGTCTGCCGATTGCTGTAACGGCTACGACTAAGGAGGAGATCCAAAAGATTGAGCGTCAGCGCAACCTCACGGTTGGCATCGCTCTTGTAGACGACGGGGGAACACTCCTGTTCGGTCATCGCGAAACGCAGCGCTTCGCCATGTGCTCGACATTTAAGTTGCCGCTGGCGGCTGCAACGCTTAAGCAAATCGAGAGCGGAAAGTGGTCTGCCGCCGAGCGGCTGAGCTATAGCGCTGGCCAATTAGATGCCTACGCGCCAGCTGCCAAGAGATATCTACCTACAGGCTACATCACGGTAGCTGAGGCTAACCAAGCCTCGGTCCAGCTCAGCGATAATACTGCTGCCAACTTGCTGCTTGACAAACTCGGAGGGCCATCGCAGCTCACATCCATGTTTCGCTCCCTCGGCGATTCCGTGAGTCGCCTGGATAGAAGAGAACCCGATTTGAACACCAACGTTTCGGGTGACCCGCGCGACACGACTACGCCGGGCGCGATGGCACGCATTGTCGCAAAGCTGGTATATGGAAACTATCTAAGTACAGCAGGCCGAGAGCAATTGCAGCGGCTTCTCATTGGCAATAACACAGGCGACTCGAGGATTCGCGCTGGAATCGCATCTGGCTGGACGACTGGCGACAAAACGGGTTCCTGCGACAATGGCGGACGAAATGACGCTGCGTTCCTGGTAAGCCCTGATGGCCGCAGATTTGCGCTGACAGTGTACCTGAACGCCCCATCGCTTGACGACAAGGCACGGAACGAGGTGGTCGCTACGGTAGCTCGCTTGGCGGTTGAGAGTATCCGCTAG | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8695|Drugs|betalactams|Class_C_betalactamases|SFDC | ATGCTGAAGAAATCCCTATCCTGTGTGCTGTTGCTCGCCACCTCAAGTTCAGTGTTTGCCGCACCGCAAACGGAAAAACAGATAGCCGACATTGTTAATCGCACCGTTGCGCCATTGATGCAAGAGCAGGGCATTCCCGGCATGGCCGTGGCGGTGATTTATCAGGGGCAGCCTTACTACTTCACCTGGGGATTGGCAGACGTTGCCGGCAAGCAACCCGTCACGCAGCAGACCTTATTCGAGCTGGGTTCGGTCAGTAAAACGTTCACAGGAGTGCTGGGCGGTGATGCCATTGCTCGCGGTGAAATCAACCTAAGCGATCCGGCGAGCAAGTACTGGCCAGCACTGTCTGGCAAGCAATGGCAGGGGATCACCTTGCTGCACCTGGCAACCTATACCGCCGGTGGCTTACCGCTGCAGATACCGGAAAATGTTACCGATGAAGCATCGCTGCAGAATTATTATCAAACCTGGCAACCGCAGTGGGCTCCGGGCACCAAGCGCCTATACTCGAACGCCAGTATTGGCCTGTTTGGCGCACTGATGGTCAAACCGTCAGGCATGAGTTTTGAACAGGCGATGACCCAACGCGTGTTCCAACCGTTGAAGCTATCGCAAACCTGGATAAACGTGCCGCAGCAGGAAGATAAGCACTACGCCTGGGGCTATCGCGATGGGAAAGCGGTTCGCGTTTCTCCGGGCATGTTTGATGCCGAAGCCTACGGCGTTAAGTCGTCGATAGAGGATATGGCAAGCTGGGTTCAGGCTAACATGGCGCCTGCTAAAGTGAAGGATGCCTCGCTGCAGAAGGGGATTACGCTTGCCCAGTCGCGCTACTGGCATGCCGGTGATATGTATCAAGGTCTGGGTTGGGAAATGCTGAACTGGCCGGTTAAAGAGAAAACTGTGGTCGAGGGTAGCGATAATAAAAACGCACTGGCAGCGCTGAGCGTCACAAAAATCACTCCGCCAGCGCCACTATCAAGCGCCTCTTGGGTACATAAAACTGGCTCAACCGGTGGATTTGGCAGCTATGTAGCCTTCATTCCTCAACAGGATCTCGGCATCGTGATGCTGGCTAACAAAAATTATCCTAATCCTGTGCGGGTTGAGGCGGCTTATCGCATTCTTGAAGCGTTACAGAAGTAA | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8417|Drugs|betalactams|Class_D_betalactamases|OXA | ATGAAACTTTTTTTTTGTTTCGCGCTTTTGATTTTAATCTCCGTAAAGGCTTTTGGACAGATCGATCTCCAGAGGCCTTTTCAAGATTGCGCGTTAGAGGGAAGCATCACCGTCTTTGATTACAAAAACAAAAAATGGACGTTCAGCGACCGGAGCGACGCGCGGCGCGAGACGCTGCCGGCTTCGACCTTTAAGGTCATCAATTCGCTGATCGCGCTCGAAACAGGCGCGGTCGAAGACGAAAAAGAGGTTTTCAAATGGGACGGCCGGCGGCGCGAGGTCGATGCGTGGAACGCCGACACCGATATGGAAAACGCTTTTCGAAATTCGACCGTCTGGTTTTATGAAGAATTGGCGAAACGCGCCGGCAAGGAAAAATACCGCGAGATTCTCAAAAAAAGCCGTTACGGAAACGGGAAAATCGACGGCGGCGAGGGCGTTAATTTCTGGGTTACCGGAGAGTTCGGCGTCACGCCGGAAAATCAGATAAAATTTTTGAAGGCGTTCTACGAAGAACGGCTTCCCTTTTCGCGCCGGAGTTTCGAGATCGTCAAACGCATCATGCTCGAAGAAAAAGCGGATAAATACACATTGCGCGCGAAAACCGGCTGGACGCGTTTCGGCGGAAAGGATACGGGCTGGTGGATCGGCTACGTCGAACGCAGCGACAATACATACTTTTTCGCCACGCGCGTAACGAAACCGCGCGAGACGCAAAACCCGCGCTTCGGCGAATGCCGCAAACTGATTACGCGCGACGTTTTGCGGCAAATGAAAATCATCGAATAG | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8212|Drugs|betalactams|Class_C_betalactamases|LAQ | ATGAAAAAATCCCTTTGCGCCGTGCTGCTGCTCACCGCTTCATGCTCTGCGCTTGCCGCGCCTCAAACTGAAAAACAGATCGCTGATACCGTCAATCGCATCATGACCCCGCTCATGAAAGAACAGGCGATTCCGGGCATGGCCGTCGCCGTGATTTATCAAGGAAAGACGCACTATTTTGTCTACGGCAAAGCAGATATCGCCGCGAATCAGCCCGTCACTCAGCACACCTTGTTTGAGCTGGGCTCCGTGAGCAAAACCTTTACCGGCGTTCTGGGCGGCGAAGCCATCGCACGCGGTGAAATCAGGCTTGACGATCCCGCCAGCAAATACTGGCCTGCGCTGACGGGTAAACAATGGAAAGGCATTACTCTGCTGCATCTGGCTACTTACACCGCAGGCGGTTTGCCGCTGCAAGTGCCGGATGAGGTAACCGATCAGGCGGCGCTTCTGCATTTCTACCAAAACTGGCAACCGCAGTGGACGCCGGGCGCAAAACGCCTGTACGCCAACGCCAGTATCGGTTTATTCGGCATGCTGGCGGTCAAGCCATCAGGGATGGATTTTGAACAGGCAATGACCTCACGCGTGTTCCAGCCGCTGGAACTCAATCACACCTGGATTAACGTCCCGGCAGCAGAGGAGAAGCATTACGCCTGGGGCTATCGTGACGGTAAACCGGTGCACGTTTCGCCCGGCATGCTTGATGCGGAATCTTACGGCGTCAAAACGACCATTGAAGATATGGCGAGCTGGGTTCGGGCCAATATGAATCCTGCGGGCGTTAAAGATGAAATGCTTAAGCAAGGAATCGAACTGGCACAGTCACGTTACTGGCGTATCGGGGAGATGTATCAGGGCTTAGGCTGGGAAATGCTGAACTGGCCGGTGAAAGCAAAAACCGTCGTCGACGGCAGCGATAACAAAATCGCACTGGCATCGCTGACGGCCGTCGAAGTGAATCCTCCCGCGCCCGCAGTTAAAGCCTCGTGGGTGCACAAGACGGGTTCAACCGGCGGATTTGGGAGCTACGTCGCCTTTATTCCTGAAAAGAACATCGGCATCGTGATGCTGGCGAATAAAAGCTATCCTAACCCTGCGCGTGTCGATGCGGCGTATCGTATCCTGGACACGTTGAAATAA | betalactams | Class C betalactamases | Drugs | 1 |
MEG_8160|Drugs|betalactams|Class_A_betalactamases|IMI | ATGTTATTTAATTCGAAGCCAAGTAGAATATCCATCCTGTTAAGCTCTTTTTTGATTTCAATATCATTTTCCTCACAGGTCAATGCAAGTGGCATTGATGAGATTAAGAAACTTGAAACAGATTTCAATGGGAGGATTGGTGTGTATGCCTTAGATACCGGCTCTGGTAAATCATTTTCATACAAAGCGAATGAACGATTTCCTCTGTGTAGTTCTTTCAAAGGTTTTTTGGCTGCTGCTGTATTAAAGGGCTCTCAAGATAACCAACTTAATATTAATCAGGTTGTAAATTACAATACAAGAAGTTTAGAATTCCATTCCCCCATTACAACTAAATATAAAGAAAATGGAATGTCTTTAGGTGATATGGCTGCTGCTGCATTACAATATAGCGACAACGCTGCTACTAATATTATCCTTGAACGTTATATTGGTGGCCCTGAGGGCATGACTAAATTCATGCGGTCGATTGGAGATAAAGATTTTAGACTTGATCGTTGGGAGTTAGATCTTAACACAGCTATTCCTGGCGATGAACGTGACACATCCACACCCGCAGCAGTTGCTAAAAGTTTAAAAAACCTTGCTCTAGGTAATATACTTAACGACCATGAAAAGGAAATCTATCAGACATGGTTAAAGGGTAACACAACTGGCGCAGCGCGTATTCGTGCTAGCGTGCCAAACGATTGGGTAGTTGGCGATAAAACCGGTAGTTGCGGAGCATACGGTACGGCAAATGATTATGCTGTAGTCTGGCCAAAGAACAGGGCTCCTCTTATCATTTCTGTGTACACTACAAAAAATGAAAAAGAAGCCAAGCATAACGATAAGTTAATTGCAGAAACTTCAAGAATTGCAATTAAAAACCTTAAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8274|Drugs|Aminoglycosides|16S_rRNA_methyltransferases|NPMB | ATGGTAAAGCAGATCCGCGGCAGCACCATCTGGCAACTAACGCGTGAAGAATTAGAGGAATGTATCAGCACGTATCGAGAGGTCGCTATCGACCTAGGTACGGGCGATGGGCGTTTTGTTTTGGACCTGGCCAAACTGGAAGCGGATACGTTCGTCATCGGAATAGATGCGAACGCGAAGCCGCTCGAAAAGCCCTCGGTCAAGATCACGCGAAAACCTGCCAAAGGCGGACTTCCGAACGCTCTCTTTGTTCAGGCCGCCGCTGAGGATCTTCCGAGTGAACTCGCCTCGGTTGCTGATAGTGTTACGGTCAATCTACCTTGGGGCAGCTTGCTCCGGGCGGTTCTTCTGCCCGATTCGGAAGTTCTTCGTGGTATTCGCCGGCTGGTAAAGCCCGGCGGCGAACTTGAGGTCGTGACCGCGATCGATCCGGTTCGCGATCTTCAGGAACTTGCCCGGCTCGGACTTTCACAGTTGACCGAGCAGCACTTCGAGACGGATCTCGTTCAGGCTTATCGAAACGCCGGATTAGAGAGGGGTAAAAACACTGGTTTCGCAAAGGCTGGTGCGCTTCCTATAGAGACGACCTGGGGCAAGCGTCTTTCCCGATCATCGGAGCGTTCGGTTCGCCGGCTAAGGTTCACCGCGGTATGA | Aminoglycosides | 16S rRNA methyltransferases | Drugs | 1 |
MEG_8424|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCCGAAAAAATTAAAATTACTCGTTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAGCTTTAGTCACACAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTCACTTATGATGGCAAAACTATTCAAACATATGGCAATGCGCTTAACCGGGCCGATCAGCGCTATATTCCGGCTTCTACTTTTAAAATGCTGAATGCTTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCTTTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTTGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGCGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGACAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCCATTGTTTATCAGGCCCTGCAACAGCTCGGTTTAATTGGGCAATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8425|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTATAAAAAAGTCCTTGTCGTTGCGACAGCTACTCTATTTTTATCTGCCTGCTCCTCTAACACGGTAAAACAACATCAAATACATTCTATTTCCGCCAATAAAAATTCAGAAGAAATTAAATATCTGTTTGATCAGGCACAGACCACAGGAGTTTTAGTGATTAAGCGTGGGCAAACCGAAGAAATTTATGGCAATGATCTTAAAAGAGCATCAACCGCTTATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTAATTGGACTTGAACATCATAAGGCAACTACAACTGAAGTATTTAAATGGGATGGGCAAAAACGTTTATTTCCTGATTGGGAAAAGGACATGACACTGGGCGATGCCATGAAAGCTTCTGCGATTCCAGTTTACCAAGAATTAGCCCGACGAATTGGTCTAGATCTTATGTCTAAAGAGGTGAAACGAATTGGTTTTGGTAATGCTAACATTGGTTCAAAAGTAGATAATTTTTGGCTCGTTGGCCCTCTAAAAATTACACCTCAACAAGAAACCCAATTTGCTTATCAATTAGCCCTTAAAACGCTTCCATTTAGCCAAGATGTACAAGAACAAGTTCAATCAATGGTGTTCATAGAGGAAAAAAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGTGGGATGTTGAACCACAAGTTGGCTGGTTAACCGGTTGGGTCATTCAACCACAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8426|Drugs|betalactams|Class_D_betalactamases|OXA | ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGAACAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATAGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGTATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGTACGGTTTGCTTATAAATTAGCCAACAAAACTCTTCCCTTTAGCAAAAATGTACAAGAACAAGTTCAATCTATGCTGTTCATTGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGATCCTCAAGTGGGTTGGTTTACAGGCTGGATCGTTCAACCTCAGGGAGAAATTATAGCTTTCTCACTTAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAGCAGCTAGGTATTTTATAG | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8427|Drugs|betalactams|Class_D_betalactamases|OXA | ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAGTTACTCCAAAACAGGAAGTCAAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGCTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCGAAAGCTGAAGGGTAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8428|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTCTAAAAAATTAAAATTACTCGCGCTATGTGCAACTGTAATCTCAGCTGCAACACTGGTCGGTTGTCAAAATATTCAGTCCCAAGCTCAACCTCTAGTCTTAAAGAAACAGACGCAGGATCAGATCGCAACTGCATTCGAAAATATCCAGACAACTGGTGTATTGGTCACCTATGATGGCAAAAAATTTCAAAAATATGGCAATGATCTCAGCCGTGCAGATCAGCGTTACATTCCTGCCTCAACTTTTAAAATGCTCAATGCCTTGATTGGTATACAGCACCATAAAACCTCACCTAATGAAGTGTTTAAATGGGATGGACAGAAGCGGGCTTTTCGTAGCTGGGAGAAGGACTTAACGCTTGCTGAGGCAATGCAGGCTTCGGCTGTACCTGTCTATCAGGAGTTGGCGCGCCGTATCGGTCTAGAATTAATGGCAAGTGAAGTAAAGCGGGTTGGCTACGGTAATCAAAATATAGGGACGCAAGTTGATAATTTTTGGTTGGTGGGGCCTTTGGAGATTACGCCAGTTGAGGAAGTGAAATTTGCTTATGCCTTAGCCAAACAGCAACTTCCATTTGATCCCTCAACACAGCAGCAAGTCAGAGATATGTTGTTGATCGAAAATGTTCAGGGAACCAGAATCTATGCCAAAAGCGGTTGGGGAATGGATGTAAATCCTCAAGTCGGACGGTGGACAGGTTGGGTCGAACAACCAAATGGTCAAGTCACTGCATTTTCGCTGAATATGGAAATGAAAAAAGCAGAACATGCGGATGCGCGTAAAGCGATTGTTTATCAAGCTTTACAACAGTTAGGTTTATTACCTCAATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8429|Drugs|betalactams|Class_D_betalactamases|OXA | ATGCCGAAAAAATTAAAATTACTCGCTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAACTTTAGTCGCGCAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTTACCTATGATGGCAAAGCTATTCAAAAATATGGCAATGCGCTTAATCGGGCCGATCAGCGCTATATTCCTGCTTCCACCTTTAAAATGTTGAATGCCTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCATTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTGGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGTGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGTCAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCTATTGTGTATCAGGCTTTACAACAACTGGGTCTATTGCCCCAATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8432|Drugs|betalactams|Class_D_betalactamases|OXA | ATGAAAAAATTTGTACTCCCTTTACTTAGTATTTCAATTTTATTGTCTTTGACTGCATGCTCATCAGTTCAAACTACATTTCAAAATGTTTCATTGGTTTCAAATGAAAAAAATAAAGAGGCTATCAAAGGTTACTTTGATGAGGCCCAAACTCAAGGTGTAATTGTTATTAAGGATAATGAACACGTTGCTATGTATGGAAATAGTTTAACACGAGCACATACACAATATGTTCCAGCATCAACATTTAAAATTTTGAATGCTTTAATTGGATTAGAGAATAATAAAGTAACCACAGATGAGATGTTTAAGTGGGATGGTAACAAAAAAGCTTTCTCAATTTGGGAAAAAGATATGAACCTAGGGGAGGCAATGAAATTATCTGCAGTTCCTGTATATCAAGAGCTTGCAAGTCGTATTGGTTTAGATTTAATGCAGAAAGAAGTAAAACGGGTTAATTTTGGTAATGCTAATATTGGAACTCAAGTCGATAATTTTTGGTTAGTTGGTCCTTTGAAGATTTCACCTATACAAGAGGTTAAATTTGCTGATGATCTTGCACATAACAAATTACCATTCAAAATAGAGACACAAGAAACAGTTAAAAATATGCTTCTAATTAAAGAAATTAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGATGGACGTTAAACCTCAAGTAGGTTGGTTAACTGGTTGGGTGGAACAGCCTACAGGGAAGATAATTTCATTTTCATTAAATTTAGAAATGAAAAAAAATATGGCAGGTTCTATCCGTAATGAAATTACTTATAAAACATTAGCGAATCTTGGGATCATTTAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8433|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTATAAAAAAGTCCTTGTCGTTGCAACAGCTACTCTATTTTTATCTGCCTGCTCTTCTAATACGGTAAAACAACACCAAATACACTCTATTTCCGCCAATAAAAATTCACAAGAAATTAAATCTCTGTTTGATCAGGCACACACCACGGGAGTTTTAGTGATTAAGCGTGGGCAGACCGAAGAAATTTTTGGCAATGATCTTAAAAGAGCATCAACAGAATATGTTCCCGCCTCTACATTTAAAATGCTAAATGCTTTAATTGGACTTGAACATCATAAAGCAACGACAGCTGAAGTATTTAAATGGGACCGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTTTAGGCGATGCAATGAAAGCTTCTGCTATTCCAGTTTATCAAGAACTAGCCCGAAGAATTGGACTTGATCTTATGGCTAAAGAGGTAAAACGTATTGGTTTCGGTAATGCGGACATTGGTTCAAAAGTAGATAATTTTTGGCTTGTCGGCCCACTTAAAATTACACCTGAACAAGAAACCCAATTTGCTTATGAATTAGCTAATAAAACTCTTCCATTTAGTAAAAATGTACAAGAACAAGTCCAATCAATGGTGTTCATAGAAGAAAAAAATGGACGTAAAATTTATGCTAAAAGTGGTTGGGGATGGGATGTTGAACCACAAGTTGGCTGGTTAACAGGCTGGGTCGTTCAACCGCAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8434|Drugs|betalactams|Class_D_betalactamases|OXA | ATGTCCCGCATTCTGTTGTCCGGCCTGCTTGCCGCCGGCCTCTTCTGTGCCTTGCCCGCCAGCGCCACCACGGGTTGCCTGCTGTTTGCCGATGGCAGCGGCAAACCCCTCAGCGCCCAGGGTGACTGCGCCAGCCAGCTGACGCCTGCCTCCACCTTCAAGATCCCACTCGCGCTGATGGGCTATGAGAGCGGCTTCCTGGTGGATGAACAGTTGCCCGCCCTGCCATTCAAAGCCGGTGACCCTGACTTCCTGCCGGAGTGGAAGCAGACCACCACCCCGAGCAACTGGATGAAATTCTCGGTGATCTGGTATTCCCAACGCCTCACCGAATGGCTGGGAGAGGCGCGCTTCCAGCAGTACGTCGACCGCTTCGACTACGGCAACCGGGAGCTCTCGGGCAACCCGGGCAAGCACGACGGTCTGACCCAGGCCTGGCTCAGCTCCAGCCTCGCCATCAGCCCCCAGGAACAGGCCCGCTTCCTCGGCAAGCTGGTGAGCGGCAAGCTGCCGGTCTCCGCCGAGGCGGTGCGCCGCACCAGCACGCTGCTGCGTCAGCCCGACATCGATGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCCAAGCTGCTGGATGGCAGCCTCAACCGGGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAGCAGGACAAGAAGCTCATCTTCGTGCACACAGTGGTGCAAAAACCCGGCAAGCAGTTCGCGTCCCTCAGGGCAAAGGAAGAGGTGTTTGCCGCCTTGCCAACAGAGCTGAAGAAACTCTGA | betalactams | Class D betalactamases | Drugs | 1 |
MEG_8208|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8209|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
MEG_8210|Drugs|betalactams|Class_A_betalactamases|KPC | ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA | betalactams | Class A betalactamases | Drugs | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.